background	NN	ROOT
:	:	punct

patentee	NN	nsubj
commence	VBD	ROOT
action	NN	dobj
against	IN	prep
competitor	NNS	pobj
,	,	punct
allege	VBG	advcl
infringement	NN	dobj
of	IN	prep
patent	NNS	pobj
direct	VBN	acl
toward	IN	prep
method	NNS	pobj
of	IN	prep
treat	VBG	pcomp
osteoporosis	NN	dobj
through	IN	prep
once	RB	advmod
monthly	JJ	amod
administration	NN	pobj
of	IN	prep
ibandronate	NN	pobj
.	.	punct

the	DT	det
United	NNP	compound
States	NNP	compound
District	NNP	compound
Court	NNP	nsubj
for	IN	prep
the	DT	det
District	NNP	pobj
of	IN	prep
New	NNP	compound
Jersey	NNP	pobj
,	,	punct
Stanley	NNP	compound
R.	NNP	compound
Chesler	NNP	conj
,	,	punct
J.	NNP	appos
,	,	punct
2011	CD	nummod
WL	NNP	appos
7121450	CD	nummod
,	,	punct
construe	VBD	ROOT
the	DT	det
patent	NN	compound
claim	NNS	dobj
,	,	punct
and	CC	cc
rule	VBD	conj
on	IN	prep
motion	NN	pobj
for	IN	prep
summary	JJ	amod
judgment	NN	pobj
that	WDT	mark
claim	NNS	nsubj
be	VBD	relcl
invalid	JJ	acomp
in	IN	prep
part	NN	pobj
,	,	punct
2012	CD	nummod
WL	NNP	appos
1637736	CD	nummod
,	,	punct
and	CC	cc
deny	VBN	conj
reconsideration	NN	dobj
,	,	punct
2013	CD	nummod
WL	NNP	appos
323335	CD	nummod
.	.	punct

patentee	NN	nsubj
appeal	VBD	ROOT
.	.	punct

 	_SP	

the	DT	det
Court	NNP	nsubj
of	IN	prep
Appeals	NNPS	pobj
,	,	punct
Bryson	NNP	conj
,	,	punct
Circuit	NNP	compound
Judge	NNP	npadvmod
,	,	punct
hold	VBD	ROOT
that	IN	det
selection	NN	dobj
of	IN	prep
once	RB	advmod
monthly	JJ	amod
oral	JJ	amod
dose	VBG	amod
regiman	NNS	pobj
of	IN	prep
ibandronate	NN	pobj
to	TO	aux
treat	VB	xcomp
osteoporosis	NN	dobj
and	CC	cc
to	TO	aux
set	VB	csubj
that	DT	det
dose	NN	dobj
at	IN	prep
150	CD	nummod
mg	NN	pobj
would	MD	aux
have	VB	aux
be	VBN	ccomp
obvious	JJ	acomp
at	IN	prep
the	DT	det
time	NN	pobj
of	IN	prep
the	DT	det
invention	NN	pobj
.	.	punct

 	_SP	

Plaintiff	NNP	compound
Hoffmann	NNP	compound
-	HYPH	punct
La	NNP	compound
Roche	NNP	nsubj
,	,	punct
Inc.	NNP	appos
,	,	punct
(	-LRB-	punct
"	``	punct
Roche	NNP	appos
"	''	punct
)	-RRB-	punct
appeal	NNS	ROOT
from	IN	prep
the	DT	det
decision	NN	pobj
of	IN	prep
the	DT	det
United	NNP	compound
States	NNP	compound
District	NNP	compound
Court	NNP	pobj
for	IN	prep
the	DT	det
District	NNP	pobj
of	IN	prep
New	NNP	compound
Jersey	NNP	pobj
grant	VBG	acl
the	DT	det
defendant	JJ	amod
generic	JJ	amod
drug	NN	compound
company	NNS	dative
summary	NN	compound
judgment	NN	dobj
of	IN	prep
invalidity	NN	pobj
as	IN	mark
to	IN	aux
claim	NNS	advcl
1	CD	npadvmod
-	SYM	punct
8	CD	prep
of	IN	prep
U.S.	NNP	compound
patent	NN	compound
No.	SYM	compound
7,718,634	CD	pobj
(	-LRB-	punct
"	``	punct
the	DT	det
¡¬634	NN	compound
patent	NN	appos
"	''	punct
)	-RRB-	punct
and	CC	cc
claim	VBZ	conj
1	CD	npadvmod
-	SYM	punct
10	CD	prep
of	IN	prep
U.S.	NNP	compound
patent	NN	compound
No.	SYM	compound
7,410,957	CD	pobj
(	-LRB-	punct
"	``	punct
the	DT	det
¡¬957	JJ	nummod
patent	NN	dobj
"	''	punct
)	-RRB-	punct
.	.	punct

-PRON-	PRP	nsubj
affirm	VBP	ROOT
.	.	punct

 	_SP	

the	DT	det
patent	NNS	nsubjpass
at	IN	prep
issue	NN	pobj
in	IN	prep
this	DT	det
appeal	NN	pobj
be	VBP	auxpass
direct	VBN	ROOT
to	IN	prep
method	NNS	pobj
of	IN	prep
treat	VBG	pcomp
osteoporosis	NN	dobj
through	IN	prep
the	DT	det
once	RB	advmod
monthly	JJ	amod
administration	NN	pobj
of	IN	prep
ibandronate	NN	pobj
,	,	punct
one	CD	appos
of	IN	prep
a	DT	det
class	NN	pobj
of	IN	prep
compound	NNS	pobj
know	VBN	acl
as	IN	prep
bisphosphonate	NNS	pobj
.	.	punct

Ibandronate	NNP	nsubj
,	,	punct
a	DT	det
salt	NN	appos
of	IN	prep
ibandronic	JJ	amod
acid	NN	pobj
,	,	punct
be	VBZ	ROOT
commercially	RB	advmod
available	JJ	acomp
as	IN	prep
Roche	NNP	pobj
's	POS	case
once	RB	advmod
monthly	JJ	advmod
boniva	JJ	compound
(r)	SYM	npadvmod
,	,	punct
which	WDT	nsubjpass
be	VBD	auxpass
approve	VBN	relcl
by	IN	agent
the	DT	det
United	NNP	nmod
States	NNP	nmod
Food	NNP	nmod
and	CC	cc
Drug	NNP	conj
Administration	NNP	pobj
(	-LRB-	punct
"	``	punct
FDA	NNP	appos
"	''	punct
)	-RRB-	punct
in	IN	prep
2005	CD	pobj
for	IN	prep
the	DT	det
treatment	NN	pobj
of	IN	prep
osteoporosis	NN	pobj
.	.	punct

Once	IN	advmod
monthly	JJ	advmod
Boniva	NNP	advcl
 	_SP	
(r)	SYM	intj
provide	VBZ	ROOT
a	DT	det
150	CD	nummod
milligram	NN	dobj
(	-LRB-	punct
"	``	punct
mg	FW	nmod
"	''	punct
)	-RRB-	punct
dose	NN	appos
of	IN	prep
ibandronate	NN	pobj
.	.	punct

 	_SP	

osteoporosis	NN	nsubj
be	VBZ	ROOT
a	DT	det
disease	NN	attr
characterize	VBN	acl
by	IN	agent
abnormal	JJ	amod
bone	NN	compound
resorption	NN	pobj
.	.	punct

resorption	NN	nsubj
,	,	punct
the	DT	det
biological	JJ	amod
process	NN	appos
by	IN	prep
which	WDT	det
bone	NN	nsubjpass
be	VBZ	auxpass
break	VBN	relcl
down	RP	prt
,	,	punct
cause	VBZ	ROOT
decrease	VBD	amod
bone	NN	compound
strength	NN	dobj
and	CC	cc
an	DT	det
increase	VBN	amod
risk	NN	conj
of	IN	prep
fracture	NNS	pobj
.	.	punct

bisphosphonate	NNS	nsubj
be	VBP	ROOT
"	``	punct
potent	JJ	amod
inhibitor	NNS	attr
of	IN	prep
bone	NN	compound
resorption	NN	pobj
"	''	punct
.	.	punct

¡¬957	JJ	compound
patent	NN	ROOT
,	,	punct
col.	NN	conj
1	CD	nummod
,	,	punct
will	UH	intj
.	.	punct

39	CD	ROOT
-	SYM	punct
40	CD	prep
.	.	punct

-PRON-	PRP	nsubj
inhibit	VBP	ROOT
abnormal	JJ	amod
bone	NN	compound
destruction	NN	dobj
and	CC	cc
enable	VB	conj
the	DT	det
gradual	JJ	amod
restoration	NN	dobj
of	IN	prep
lose	VBN	amod
bone	NN	compound
mineral	NN	compound
density	NN	pobj
(	-LRB-	punct
"	``	punct
BMD	NNP	ccomp
"	''	punct
)	-RRB-	punct
.	.	punct

 	_SP	

bisphosphonate	NNS	nsubjpass
be	VBP	auxpass
generally	RB	advmod
know	VBN	ROOT
to	TO	aux
have	VB	xcomp
a	DT	det
low	JJ	amod
bioavailability	NN	dobj
when	WRB	advmod
administer	VBD	advcl
orally	RB	advmod
,	,	punct
i.e.	FW	advmod
,	,	punct
only	RB	advmod
a	DT	det
small	JJ	amod
fraction	NN	nsubjpass
of	IN	prep
a	DT	det
give	VBN	amod
dose	NN	pobj
be	VBZ	auxpass
absorb	VBN	advcl
into	IN	prep
the	DT	det
blood	NN	pobj
.	.	punct

additionally	RB	advmod
,	,	punct
oral	JJ	amod
administration	NN	nsubj
of	IN	prep
bisphosphonate	NNS	pobj
can	MD	aux
result	VB	ROOT
in	IN	prep
adverse	JJ	amod
esophageal	NN	amod
and	CC	cc
gastrointestinal	JJ	conj
side	NN	compound
effect	NNS	pobj
.	.	punct

As	IN	prep
a	DT	det
result	NN	pobj
of	IN	prep
the	DT	det
side	NN	compound
effect	NNS	pobj
and	CC	cc
to	TO	aux
improve	VB	conj
the	DT	det
bioavailability	NN	dobj
of	IN	prep
the	DT	det
drug	NN	pobj
,	,	punct
patient	NNS	nsubj
take	VBG	acl
bisphosphonate	NNS	dobj
must	MD	aux
adhere	VB	ROOT
to	IN	prep
a	DT	det
dosing	JJ	amod
regimen	NN	pobj
that	WDT	nsubj
require	VBZ	relcl
a	DT	det
bisphosphonate	JJ	compound
tablet	NN	dobj
to	TO	aux
be	VB	auxpass
take	VBN	relcl
in	IN	prep
a	DT	det
fast	VBG	amod
state	NN	pobj
at	IN	advmod
least	RBS	advmod
30	CD	nummod
minute	NNS	npadvmod
before	IN	prep
eat	VBG	pcomp
or	CC	cc
drink	VBG	conj
.	.	punct

In	IN	prep
the	DT	det
past	NN	pobj
,	,	punct
the	DT	det
inconvenience	NN	nsubj
of	IN	prep
that	DT	det
regimen	NN	pobj
create	VBD	ROOT
problem	NNS	dobj
of	IN	prep
patient	JJ	amod
compliance	NN	pobj
.	.	punct

researcher	NNS	nsubj
in	IN	prep
the	DT	det
field	NN	pobj
believe	VBD	ROOT
that	IN	mark
less	RBR	advmod
-	HYPH	punct
frequent	JJ	amod
dosing	NN	nsubj
would	MD	aux
result	VB	ccomp
in	IN	prep
patient	NNS	pobj
continue	VBG	acl
the	DT	det
treatment	NN	dobj
for	IN	prep
the	DT	det
long	JJ	amod
term	NN	pobj
,	,	punct
which	WDT	nsubjpass
be	VBZ	auxpass
require	VBN	relcl
for	IN	prep
bisphosphonate	JJ	compound
treatment	NNS	pobj
to	TO	aux
be	VB	advcl
successful	JJ	acomp
.	.	punct

 	_SP	

Roche	NNP	nsubj
own	VBZ	ROOT
the	DT	det
¡¬634	NN	compound
patent	NN	dobj
and	CC	cc
the	DT	det
¡¬957	JJ	amod
patent	NN	conj
,	,	punct
which	WDT	nsubj
be	VBZ	relcl
the	DT	det
parent	NN	attr
of	IN	prep
the	DT	det
¡¬634	JJ	compound
patent	NN	pobj
.	.	punct

claim	NNS	nsubj
1	CD	nummod
-	SYM	punct
8	CD	prep
of	IN	prep
the	DT	det
¡¬634	NN	compound
patent	NN	pobj
and	CC	cc
claim	VBZ	conj
1	CD	npadvmod
-	SYM	punct
10	CD	prep
of	IN	prep
the	DT	det
¡¬	NNP	nmod
957	CD	nummod
patent	NN	pobj
be	VBP	ROOT
at	IN	prep
issue	NN	pobj
in	IN	prep
this	DT	det
case	NN	pobj
and	CC	cc
describe	VB	conj
a	DT	det
method	NN	dobj
of	IN	prep
treat	VBG	pcomp
osteoporosis	NN	dobj
consist	VBG	xcomp
of	IN	prep
orally	RB	advmod
administer	VBG	pcomp
about	RB	advmod
150	CD	nummod
mg	NN	dobj
of	IN	prep
ibandronic	JJ	amod
acid	NN	pobj
once	RB	advmod
monthly	RB	advmod
on	IN	prep
a	DT	det
single	JJ	amod
day	NN	pobj
.	.	punct

Claim	NNP	nsubj
1	CD	nummod
of	IN	prep
the	DT	det
¡¬634	NN	compound
patent	NN	pobj
be	VBZ	ROOT
representative	JJ	acomp
of	IN	prep
the	DT	det
claim	NNS	pobj
on	IN	prep
appeal	NN	pobj
:	:	punct

 	_SP	

1	CD	ROOT
.	.	punct

a	DT	det
method	NN	nsubj
for	IN	prep
treat	VBG	pcomp
or	CC	cc
inhibit	VBG	conj
postmenopausal	NN	amod
osteoporosis	NN	dobj
in	IN	prep
a	DT	det
postmenopausal	JJ	amod
woman	NN	pobj
in	IN	prep
need	NN	pobj
of	IN	prep
treatment	NN	pobj
or	CC	cc
inhibition	NN	conj
of	IN	prep
postmenopausal	NN	amod
osteoporosis	NN	pobj
by	IN	prep
administration	NN	pobj
of	IN	prep
a	DT	det
pharmaceutically	RB	advmod
acceptable	JJ	amod
salt	NN	pobj
of	IN	prep
ibandronic	JJ	amod
acid	NN	pobj
,	,	punct
comprising	NN	ROOT
:	:	punct

 	_SP	
(	-LRB-	punct
a	DT	meta
)	-RRB-	punct
commence	VBG	advcl
the	DT	det
administration	NN	dobj
of	IN	prep
the	DT	det
pharmaceutically	RB	advmod
acceptable	JJ	amod
salt	NN	pobj
of	IN	prep
ibandronic	JJ	amod
acid	NN	pobj
by	IN	prep
orally	RB	advmod
administer	VBG	pcomp
to	IN	prep
the	DT	det
postmenopausal	NN	amod
woman	NN	pobj
,	,	punct
on	IN	prep
a	DT	det
single	JJ	amod
day	NN	pobj
,	,	punct
a	DT	det
first	JJ	amod
dose	NN	dep
in	IN	prep
the	DT	det
form	NN	pobj
of	IN	prep
a	DT	det
tablet	NN	pobj
,	,	punct
wherein	WRB	advmod
the	DT	det
tablet	NN	nsubj
comprise	VBZ	ccomp
an	DT	det
amount	NN	dobj
of	IN	prep
the	DT	det
pharmaceutically	RB	advmod
acceptable	JJ	amod
salt	NN	pobj
of	IN	prep
ibandronic	JJ	amod
acid	NN	pobj
that	WDT	nsubj
be	VBZ	relcl
equivalent	JJ	acomp
to	IN	prep
about	RB	advmod
150	CD	nummod
mg	NN	pobj
of	IN	prep
ibandronic	JJ	amod
acid	NN	pobj
;	:	punct
and	CC	cc

 	_SP	
(	-LRB-	punct
b	LS	meta
)	-RRB-	punct
continue	VBG	conj
the	DT	det
administration	NN	dobj
by	IN	prep
orally	RB	advmod
administer	VBG	pcomp
,	,	punct
once	RB	advmod
monthly	RB	advmod
on	IN	prep
a	DT	det
single	JJ	amod
day	NN	pobj
,	,	punct
a	DT	det
tablet	NN	npadvmod
comprise	VBG	acl
an	DT	det
amount	NN	dobj
of	IN	prep
the	DT	det
pharmaceutically	RB	advmod
acceptable	JJ	amod
salt	NN	pobj
of	IN	prep
ibandronic	JJ	amod
acid	NN	pobj
that	WDT	nsubj
be	VBZ	relcl
equivalent	JJ	acomp
to	IN	prep
about	RB	advmod
150	CD	nummod
mg	NN	pobj
of	IN	prep
ibandronic	JJ	amod
acid	NN	pobj
.	.	punct

 	_SP	

the	DT	det
defendant	NNS	nsubj
in	IN	prep
this	DT	det
case	NN	pobj
be	VBP	ROOT
generic	JJ	amod
drug	NN	compound
manufacturer	NNS	attr
who	WP	nsubj
submit	VBD	relcl
Abbreviated	NNP	amod
New	NNP	compound
Drug	NNP	compound
Applications	NNPS	dobj
(	-LRB-	punct
"	``	punct
anda	NNS	appos
"	''	punct
)	-RRB-	punct
to	IN	prep
the	DT	det
FDA	NNP	pobj
for	IN	prep
approval	NN	pobj
to	TO	aux
engage	VB	acl
in	IN	prep
the	DT	det
manufacture	NN	pobj
and	CC	cc
sale	NN	conj
of	IN	prep
generic	JJ	amod
version	NNS	pobj
of	IN	prep
Boniva	NNP	compound
(r)	SYM	pobj
prior	RB	advmod
to	IN	prep
the	DT	det
expiration	NN	pobj
of	IN	prep
Roche	NNP	poss
's	POS	case
patent	NNS	pobj
.	.	punct

Roche	NNP	nsubj
sue	VBD	ROOT
the	DT	det
defendant	NNS	dobj
in	IN	prep
the	DT	det
United	NNP	compound
States	NNP	compound
District	NNP	compound
Court	NNP	pobj
for	IN	prep
the	DT	det
District	NNP	nsubj
of	IN	prep
New	NNP	compound
Jersey	NNP	pobj
alleging	NN	pcomp
infringement	NN	dobj
under	IN	prep
35	CD	pobj
u.s.c.	NN	npadvmod
¡±	NNP	punct
271(e)(2	CD	npadvmod
)	-RRB-	punct
base	VBN	prep
on	IN	prep
the	DT	det
defendant	NNS	poss
'	POS	case
ANDA	NNP	compound
filing	NNS	pobj
.	.	punct

 	_SP	

Roche	NNP	nsubj
move	VBD	ROOT
for	IN	prep
a	DT	det
preliminary	JJ	amod
injunction	NN	pobj
.	.	punct

the	DT	det
district	NN	compound
court	NN	nsubj
deny	VBD	ROOT
the	DT	det
motion	NN	dobj
,	,	punct
hold	VBG	advcl
that	IN	mark
Roche	NNP	nsubj
have	VBD	aux
fail	VBN	ccomp
to	TO	aux
prove	VB	xcomp
-PRON-	PRP	nsubj
be	VBD	ccomp
likely	JJ	acomp
to	TO	aux
succeed	VB	xcomp
in	IN	prep
defeat	VBG	pcomp
the	DT	det
defendant	NNS	poss
'	POS	case
obviousness	JJ	amod
challenge	NN	dobj
.	.	punct

This	DT	det
court	NN	nsubj
affirm	VBD	ROOT
the	DT	det
district	NN	compound
court	NN	poss
's	POS	case
denial	NN	dobj
of	IN	prep
the	DT	det
preliminary	JJ	amod
injunction	NN	pobj
.	.	punct

see	VB	ROOT
Hoffmann	NNP	compound
-	HYPH	punct
La	NNP	compound
Roche	NNP	compound
Inc.	NNP	dobj
v.	CC	prep
Apotex	NNP	compound
Inc.	NNP	conj
,	,	punct
496	CD	nummod
Fed	NNP	appos
.	.	punct

appx	NN	ROOT
.	.	punct

46	CD	ROOT
(	-LRB-	punct
Fed	NNP	nmod
.	.	punct
Cir.2012	NNS	appos
)	-RRB-	punct
.	.	punct

 	_SP	

While	IN	mark
the	DT	det
appeal	NN	nsubj
of	IN	prep
the	DT	det
preliminary	JJ	amod
injunction	NN	compound
decision	NN	pobj
be	VBD	advcl
pende	VBG	acomp
,	,	punct
the	DT	det
district	NN	compound
court	NN	nsubj
grant	VBD	ROOT
the	DT	det
defendant	NNS	poss
'	POS	case
motion	NN	dobj
for	IN	prep
summary	JJ	amod
judgment	NN	pobj
of	IN	prep
invalidity	NN	pobj
of	IN	prep
claim	NNS	pobj
1	CD	npadvmod
-	SYM	punct
8	CD	prep
of	IN	prep
the	DT	det
¡¬634	NN	compound
patent	NN	pobj
due	IN	prep
to	IN	pcomp
obviousness	JJ	pobj
under	IN	prep
35	CD	pobj
u.s.c.	NN	npadvmod
¡±	NNP	punct
103(a	CD	appos
)	-RRB-	punct
.	.	punct

As	IN	prep
to	IN	prep
the	DT	det
frequency	NN	pobj
of	IN	prep
dosing	NN	pobj
,	,	punct
the	DT	det
court	NN	nsubj
find	VBD	ROOT
that	IN	mark
once	IN	mark
monthly	JJ	amod
oral	JJ	amod
dosing	NN	nsubjpass
of	IN	prep
ibandronate	NN	pobj
be	VBD	auxpass
establish	VBN	ccomp
in	IN	prep
the	DT	det
prior	JJ	amod
art	NN	pobj
.	.	punct

As	IN	prep
to	IN	prep
the	DT	det
amount	NN	pobj
of	IN	prep
the	DT	det
monthly	JJ	amod
dose	NN	pobj
,	,	punct
the	DT	det
court	NN	nsubj
find	VBD	ROOT
that	IN	mark
the	DT	det
combination	NN	nsubj
of	IN	prep
several	JJ	amod
prior	JJ	amod
art	NN	compound
reference	NNS	pobj
suggest	VBD	ccomp
a	DT	det
dosage	NN	compound
level	NN	dobj
of	IN	prep
about	RB	advmod
150	CD	nummod
mg	NN	pobj
per	IN	prep
month	NN	pobj
,	,	punct
or	CC	cc
at	IN	advmod
least	JJS	advmod
indicate	VBD	conj
that	IN	mark
a	DT	det
monthly	JJ	amod
dose	NN	nsubj
of	IN	prep
150	CD	nummod
mg	NN	pobj
be	VBD	ccomp
obvious	JJ	acomp
to	TO	aux
try	VB	xcomp
.	.	punct

 	_SP	

the	DT	det
district	NN	compound
court	NN	nsubj
consider	VBD	ROOT
Roche	NNP	poss
's	POS	case
evidence	NN	dobj
of	IN	prep
objective	JJ	amod
consideration	NNS	pobj
of	IN	prep
nonobviousness	NN	pobj
but	CC	cc
conclude	VBD	conj
that	IN	mark
"	``	punct
Roche	NNP	poss
's	POS	case
objective	JJ	amod
consideration	NNS	compound
evidence	NN	nsubj
do	VBZ	aux
not	RB	neg
rise	VB	ccomp
to	IN	prep
the	DT	det
level	NN	pobj
of	IN	prep
a	DT	det
mere	JJ	amod
scintilla	NN	pobj
,	,	punct
and	CC	cc
-PRON-	PRP	nsubj
be	VBZ	conj
not	RB	neg
sufficient	JJ	acomp
to	TO	aux
defeat	VB	xcomp
the	DT	det
motion	NN	dobj
for	IN	prep
summary	NN	amod
judgment	NN	pobj
"	''	punct
.	.	punct

In	IN	prep
response	NN	pobj
to	IN	prep
Roche	NNP	poss
's	POS	case
argument	NN	pobj
that	IN	mark
the	DT	det
150	CD	nummod
mg	NN	dep
once	RB	mark
monthly	JJ	amod
dose	NN	nsubj
give	VBD	acl
result	NNS	dobj
that	WDT	nsubj
be	VBD	relcl
superior	JJ	acomp
to	IN	prep
a	DT	det
2.5	CD	nummod
mg	NN	nmod
daily	JJ	amod
dose	NN	pobj
,	,	punct
the	DT	det
court	NN	nsubj
find	VBD	ROOT
that	IN	mark
Roche	NNP	nsubj
have	VBD	aux
"	``	punct
point	VBN	ccomp
to	IN	prep
no	DT	det
evidence	NN	pobj
in	IN	prep
support	NN	pobj
of	IN	prep
[	-LRB-	punct
-PRON-	PRP$	poss
]	-RRB-	punct
claim	NN	pobj
that	IN	mark
the	DT	det
skilled	JJ	amod
artisan	NN	nsubj
would	MD	aux
have	VB	aux
be	VBN	acl
surprise	VBN	acomp
that	IN	mark
the	DT	det
150	CD	nummod
mg	NN	nmod
once	RB	advmod
-	HYPH	punct
monthly	JJ	amod
dose	NN	nsubj
be	VBD	ccomp
superior	JJ	acomp
to	IN	prep
the	DT	det
2.5	CD	nummod
mg	NN	nmod
daily	JJ	amod
dose	NN	pobj
"	''	punct
.	.	punct

the	DT	det
court	NN	nsubj
refuse	VBD	ROOT
to	TO	aux
consider	VB	xcomp
contention	NNS	dobj
,	,	punct
raise	VBN	acl
at	IN	prep
oral	JJ	amod
argument	NN	pobj
,	,	punct
that	IN	mark
the	DT	det
150	CD	nummod
mg	NN	compound
dose	NN	nsubj
have	VBD	ccomp
a	DT	det
superior	JJ	amod
and	CC	cc
unexpected	JJ	conj
level	NN	dobj
of	IN	prep
bioavailability	NN	pobj
,	,	punct
because	IN	mark
Roche	NNP	nsubj
have	VBD	aux
not	RB	neg
raise	VBN	advcl
that	DT	det
argument	NN	dobj
in	IN	prep
-PRON-	PRP$	poss
opposition	NN	compound
brief	NN	pobj
.	.	punct

 	_SP	

pursuant	JJ	advmod
to	IN	prep
Federal	NNP	compound
Rule	NNP	pobj
of	IN	prep
Civil	NNP	compound
Procedure	NNP	pobj
56(f	NNP	nummod
)	-RRB-	punct
the	DT	det
court	NN	nsubj
then	RB	advmod
raise	VBD	ROOT
,	,	punct
on	IN	prep
-PRON-	PRP$	poss
own	JJ	amod
motion	NN	pobj
,	,	punct
the	DT	det
issue	NN	appos
of	IN	prep
summary	JJ	amod
judgment	NN	pobj
of	IN	prep
invalidity	NN	pobj
of	IN	prep
claim	NNS	pobj
1	CD	npadvmod
-	SYM	punct
10	CD	prep
of	IN	prep
the	DT	det
¡¬957	JJ	amod
patent	NN	pobj
.	.	punct

After	IN	prep
consider	VBG	pcomp
the	DT	det
party	NNS	poss
'	POS	case
submission	NNS	dobj
,	,	punct
the	DT	det
court	NN	nsubj
hold	VBD	ROOT
those	DT	det
claim	NNS	dobj
invalid	JJ	oprd
for	IN	prep
the	DT	det
same	JJ	amod
reason	NNS	pobj
that	WDT	nsubj
apply	VBD	relcl
to	IN	prep
the	DT	det
claim	NNS	pobj
of	IN	prep
the	DT	det
¡¬	NNP	nmod
634	CD	nummod
patent	NN	pobj
.	.	punct

Roche	NNP	nsubj
argue	VBD	ROOT
that	IN	mark
-PRON-	PRP	nsubj
be	VBD	ccomp
unexpected	JJ	acomp
that	IN	mark
an	DT	det
intermittent	JJ	amod
ibandronate	NN	compound
regiman	NNS	nsubj
would	MD	aux
be	VB	ccomp
effective	JJ	acomp
in	IN	prep
reduce	VBG	pcomp
fracture	NNS	dobj
.	.	punct

but	CC	cc
the	DT	det
court	NN	nsubj
conclude	VBD	ROOT
that	IN	mark
the	DT	det
evidence	NN	nsubj
on	IN	prep
which	WDT	pobj
Roche	NNP	nsubj
rely	VBD	relcl
fail	VBD	ccomp
to	TO	aux
show	VB	xcomp
that	IN	mark
a	DT	det
person	NN	nsubj
of	IN	prep
skill	NN	pobj
in	IN	prep
the	DT	det
art	NN	pobj
would	MD	aux
not	RB	neg
have	VB	aux
have	VBN	ccomp
a	DT	det
reasonable	JJ	amod
expectation	NN	dobj
that	IN	mark
the	DT	det
patented	JJ	amod
method	NN	nsubj
would	MD	aux
succeed	VB	acl
in	IN	prep
reduce	VBG	pcomp
fracture	NNS	dobj
.	.	punct

the	DT	det
court	NN	nsubj
explain	VBD	ROOT
that	IN	dobj
"	``	punct
empirical	JJ	amod
confirmation	NN	pobj
that	IN	mark
a	DT	det
method	NN	nsubj
for	IN	prep
increase	VBG	amod
bone	NN	compound
mineral	NN	compound
density	NN	pobj
help	VBZ	acl
increase	VB	xcomp
bone	NN	compound
strength	NN	dobj
enough	RB	advmod
that	IN	mark
bone	NNS	nsubj
break	VBP	nsubj
less	RBR	advmod
easily	RB	advmod
would	MD	aux
not	RB	neg
appear	VB	ccomp
to	TO	aux
be	VB	xcomp
all	DT	attr
that	RB	advmod
surprising	JJ	acomp
"	''	punct
.	.	punct

 	_SP	

In	IN	prep
-PRON-	PRP$	poss
motion	NN	pobj
for	IN	prep
reconsideration	NN	pobj
,	,	punct
Roche	NNP	nsubj
argue	VBD	ROOT
that	IN	mark
the	DT	det
district	NN	compound
court	NN	nsubj
have	VBD	aux
improperly	RB	advmod
fail	VBN	ccomp
to	TO	aux
consider	VB	xcomp
evidence	NN	dobj
that	IN	mark
the	DT	det
150	CD	nummod
mg	NN	compound
dose	NN	nsubj
of	IN	prep
ibandronate	NN	pobj
show	VBD	acl
an	DT	det
unexpected	JJ	amod
level	NN	dobj
of	IN	prep
bioavailability	NN	pobj
as	IN	mark
compare	VBN	prep
with	IN	prep
low	JJR	amod
dos	NNS	pobj
.	.	punct

On	IN	prep
the	DT	det
merit	NNS	pobj
of	IN	prep
that	DT	det
argument	NN	pobj
,	,	punct
the	DT	det
district	NN	compound
court	NN	nsubj
find	VBD	ROOT
that	IN	mark
the	DT	det
"	``	punct
evidence	NN	nsubj
that	IN	mark
the	DT	det
150	CD	nummod
mg	NN	compound
dosage	NN	nsubjpass
be	VBD	auxpass
absorb	VBN	acl
better	RBR	advmod
by	IN	agent
the	DT	det
body	NN	pobj
simply	RB	advmod
have	VBZ	ccomp
no	DT	det
relevance	NN	dobj
to	IN	prep
the	DT	det
core	NN	pobj
find	VBG	acl
that	IN	mark
the	DT	det
difference	NN	nsubj
between	IN	prep
the	DT	det
150	CD	nummod
mg	NN	compound
dose	NN	pobj
and	CC	cc
the	DT	det
prior	JJ	amod
art	NN	nsubj
be	VBD	ccomp
small	JJ	acomp
"	''	punct
and	CC	cc
that	IN	mark
there	EX	expl
be	VBD	conj
a	DT	det
reasonable	JJ	amod
expectation	NN	attr
of	IN	prep
success	NN	pobj
with	IN	prep
the	DT	det
150	CD	nummod
mg	NN	compound
dose	NN	pobj
.	.	punct

 	_SP	

Roche	NNP	nsubj
timely	RB	advmod
appeal	VBD	ROOT
the	DT	det
grant	NNS	dobj
of	IN	prep
summary	JJ	amod
judgment	NN	pobj
of	IN	prep
obviousness	NN	pobj
.	.	punct

  	_SP	

the	DT	det
issue	NN	nsubj
in	IN	prep
this	DT	det
case	NN	pobj
be	VBZ	ROOT
whether	IN	mark
-PRON-	PRP	nsubj
would	MD	aux
have	VB	aux
be	VBN	ccomp
obvious	JJ	acomp
at	IN	prep
the	DT	det
time	NN	pobj
of	IN	prep
invention	NN	pobj
to	TO	aux
select	VB	advcl
a	DT	det
once	RB	advmod
monthly	JJ	advmod
oral	JJ	amod
dose	VBG	amod
regiman	NNS	dobj
of	IN	prep
ibandronate	NN	pobj
to	TO	aux
treat	VB	xcomp
osteoporosis	NN	dobj
and	CC	cc
to	TO	aux
set	VB	conj
that	DT	det
dose	NN	dobj
at	IN	prep
150	CD	nummod
mg	NN	pobj
.	.	punct

 	_SP	

a.	NN	compound
Monthly	NNP	compound
Dosing	NNP	ROOT

 	_SP	
1	CD	punct
.	.	punct

a	DT	det
relatively	RB	advmod
infrequent	JJ	amod
dose	VBG	compound
schedule	NN	nsubjpass
have	VBZ	aux
long	RB	advmod
be	VBN	auxpass
view	VBN	ROOT
as	IN	prep
a	DT	det
potential	JJ	amod
solution	NN	pobj
to	IN	prep
the	DT	det
problem	NN	pobj
of	IN	prep
patient	JJ	amod
compliance	NN	pobj
stem	VBG	acl
from	IN	prep
the	DT	det
inconvenience	NN	pobj
of	IN	prep
oral	JJ	amod
bisphosphonate	NN	compound
regimen	NNS	pobj
.	.	punct
Fosamax	NNP	compound
(r)	SYM	npadvmod
,	,	punct
a	DT	det
prior	JJ	amod
art	NN	compound
bisphosphonate	JJ	compound
product	NN	nsubjpass
sell	VBN	acl
by	IN	agent
Merck	NNP	pobj
&	CC	cc
Co.	NNP	conj
,	,	punct
be	VBD	auxpass
administer	VBN	relcl
weekly	RB	oprd
,	,	punct
and	CC	cc
several	JJ	amod
prior	JJ	amod
art	NN	compound
reference	NNS	nsubj
teach	VBD	conj
once	IN	advmod
monthly	JJ	amod
oral	JJ	amod
dosing	NN	pobj
of	IN	prep
ibandronate	NN	pobj
or	CC	cc
other	JJ	amod
bisphosphonate	NNS	conj
.	.	punct

 	_SP	

first	RB	advmod
,	,	punct
an	DT	det
article	NN	nsubj
in	IN	prep
the	DT	det
trade	NN	compound
journal	NN	pobj
Lunar	NNP	compound
News	NNP	nsubj
entitle	VBN	acl
Update	NNP	oprd
:	:	punct
Bisphosphonates	NNP	appos
(	-LRB-	punct
"	``	punct
Lunar	NNP	compound
News	NNP	appos
"	''	punct
)	-RRB-	punct
state	VBD	ROOT
that	IN	mark
"	``	punct
researcher	NNS	nsubj
be	VBP	aux
seek	VBG	ccomp
solution	NNS	dobj
for	IN	prep
well	JJR	amod
compliance	NN	pobj
,	,	punct
"	''	punct
include	VBG	prep
approach	NNS	pobj
that	IN	nsubj
"	``	punct
use	VBP	relcl
bisphosphonate	NNS	dobj
with	IN	prep
high	JJ	amod
potency	NN	pobj
yet	CC	advmod
low	JJ	amod
irritability	NN	dobj
,	,	punct
such	JJ	amod
as	IN	prep
...	NFP	punct
ibandronate	NN	pcomp
(	-LRB-	punct
Roche	NNP	dobj
)	-RRB-	punct
.	.	punct

oral	JJ	amod
agent	NNS	nsubjpass
could	MD	aux
be	VB	auxpass
give	VBN	ROOT
intermittently	RB	advmod
(	-LRB-	punct
once	RB	advmod
/	SYM	punct
month	NN	appos
,	,	punct
for	IN	prep
example	NN	pobj
)	-RRB-	punct
and	CC	cc
still	RB	advmod
be	VB	conj
quite	RB	advmod
potent	JJ	acomp
"	''	punct
.	.	punct

second	RB	advmod
,	,	punct
a	DT	det
2001	CD	nummod
article	NN	nsubj
by	IN	prep
Carey	NNP	compound
Krause	NNP	pobj
in	IN	prep
Chemical	NNP	compound
Market	NNP	compound
reporter	NN	pobj
(	-LRB-	punct
"	``	punct
Krause	NNP	appos
"	''	punct
)	-RRB-	punct
disclose	VBD	ROOT
that	IN	mark
Roche	NNP	nsubj
would	MD	aux
likely	RB	advmod
seek	VB	ccomp
FDA	NNP	compound
approval	NN	dobj
of	IN	prep
an	DT	det
"	``	punct
oral	JJ	amod
once	RB	advmod
-	HYPH	punct
monthly	JJ	amod
"	''	punct
formulation	NN	pobj
of	IN	prep
ibandronate	NN	pobj
in	IN	prep
2003	CD	pobj
.	.	punct

finally	RB	advmod
,	,	punct
United	NNP	compound
States	NNP	compound
patent	NN	compound
No.	SYM	nsubj
6,468,559	CD	nummod
(	-LRB-	punct
"	``	punct
Chen	NNP	appos
"	''	punct
)	-RRB-	punct
disclose	VBD	ROOT
coated	JJ	amod
-	HYPH	punct
dosage	NN	compound
form	NNS	dobj
of	IN	prep
bisphosphonic	JJ	amod
acid	NNS	pobj
and	CC	cc
method	NNS	conj
for	IN	prep
orally	RB	advmod
administer	VBG	pcomp
those	DT	det
dosage	NN	compound
form	NNS	dobj
.	.	punct

ibandronic	JJ	amod
acid	NN	nsubjpass
be	VBD	auxpass
identify	VBN	ROOT
as	IN	prep
one	CD	pobj
of	IN	prep
many	JJ	amod
known	JJ	amod
bisphosphonic	JJ	amod
acid	NNS	pobj
.	.	punct

Chen	NNP	nsubj
disclose	VBD	ROOT
a	DT	det
preferred	JJ	amod
embodiment	NN	dobj
in	IN	prep
which	WDT	pobj
"	``	punct
a	DT	det
dosage	NN	compound
form	NN	nsubjpass
of	IN	prep
the	DT	det
invention	NN	pobj
be	VBZ	auxpass
administer	VBN	relcl
to	IN	prep
a	DT	det
patient	NN	pobj
...	:	punct
preferably	RB	advmod
once	RB	advmod
a	DT	det
month	NN	npadvmod
"	''	punct
.	.	punct

Lunar	NNP	compound
News	NNP	nsubj
,	,	punct
Krause	NNP	conj
,	,	punct
and	CC	cc
Chen	NNP	conj
therefore	RB	advmod
specifically	RB	advmod
teach	VBD	ROOT
the	DT	det
monthly	JJ	amod
administration	NN	dobj
of	IN	prep
ibandronate	NN	pobj
.	.	punct

 	_SP	

similarly	RB	advmod
,	,	punct
the	DT	det
prior	JJ	amod
art	NN	nsubj
contain	VBD	ROOT
reference	NNS	dobj
to	IN	prep
the	DT	det
monthly	JJ	amod
oral	JJ	amod
administration	NN	pobj
of	IN	prep
bisphosphonate	NNS	pobj
in	IN	prep
general	JJ	amod
.	.	punct

United	NNP	compound
States	NNP	compound
Patent	NNP	compound
Application	NNP	nsubj
no.2003/0118634	NN	appos
(	-LRB-	punct
"	``	punct
Schofield	NNP	appos
"	''	punct
)	-RRB-	punct
teach	VBD	ROOT
dosing	NN	dobj
of	IN	prep
"	``	punct
bone	NN	nmod
-	HYPH	punct
active	JJ	amod
phosponate	NNS	pobj
"	''	punct
and	CC	cc
refer	VBD	conj
to	IN	prep
equivalent	JJ	amod
dos	NNS	pobj
that	IN	mark
"	``	punct
can	MD	aux
be	VB	auxpass
give	VBN	ccomp
every	DT	det
other	JJ	amod
day	NN	npadvmod
,	,	punct
twice	RB	predet
a	DT	det
week	NN	appos
,	,	punct
weekly	JJ	conj
,	,	punct
biweekly	RB	conj
or	CC	cc
monthly	JJ	conj
"	''	punct
.	.	punct

United	NNP	compound
States	NNP	compound
patent	NN	compound
No.	SYM	nsubj
5,616,560	CD	nummod
(	-LRB-	punct
"	``	punct
Geddes	NNP	appos
"	''	punct
)	-RRB-	punct
disclose	VBD	ROOT
a	DT	det
bisphosphonate	JJ	compound
administration	NN	compound
regiman	NNS	dobj
in	IN	prep
which	WDT	pobj
"	''	punct
say	VBD	relcl
bisphosphonate	NN	nsubjpass
be	VBZ	auxpass
administer	VBN	ccomp

at	IN	advmod
least	JJS	advmod
1	CD	nummod
day	NN	nsubj
of	IN	prep
every	DT	pobj
say	VBD	ROOT
thirty(30)-day	CD	npadvmod
treatment	NN	compound
period	NN	npadvmod
"	''	punct
.	.	punct

 	_SP	

2	CD	ROOT
.	.	punct

Roche	NNP	nsubj
argue	VBZ	ROOT
that	IN	mark
the	DT	det
art	NN	nsubj
teach	VBD	ccomp
away	RB	advmod
from	IN	prep
once	RB	advmod
monthly	RB	amod
dose	VBG	pobj
because	IN	prep
,	,	punct
accord	VBG	prep
to	IN	prep
Roche	NNP	pobj
,	,	punct
-PRON-	PRP	nsubjpass
be	VBD	auxpass
widely	RB	advmod
believe	VBN	conj
as	IN	prep
of	IN	prep
the	DT	det
date	NN	pobj
of	IN	prep
invention	NN	pobj
that	IN	mark
a	DT	det
bisphosphonate	NN	compound
regimen	NN	nsubj
with	IN	prep
a	DT	det
dose	NN	npadvmod
-	HYPH	punct
free	JJ	amod
interval	NN	pobj
longer	RBR	advmod
than	IN	mark
one	CD	nummod
or	CC	cc
two	CD	conj
week	NNS	nsubj
would	MD	aux
not	RB	neg
be	VB	conj
effective	JJ	acomp
.	.	punct

to	TO	aux
support	VB	advcl
that	DT	det
contention	NN	dobj
,	,	punct
Roche	NNP	nsubj
primarily	RB	advmod
rely	VBZ	ROOT
on	IN	prep
the	DT	det
alleged	JJ	amod
failure	NN	pobj
of	IN	prep
-PRON-	PRP$	poss
intravenous	JJ	amod
ibandronate	NN	compound
study	NN	pobj
(	-LRB-	punct
"	``	punct
Recker	NNP	appos
"	''	punct
)	-RRB-	punct
to	TO	aux
demonstrate	VB	advcl
antifracture	NN	compound
efficacy	NN	dobj
with	IN	prep
quarterly	JJ	amod
dose	VBG	pobj
.	.	punct

secondarily	RB	advmod
,	,	punct
Roche	NNP	nsubj
rely	VBZ	ROOT
on	IN	prep
a	DT	det
prior	JJ	amod
art	NN	compound
article	NN	pobj
by	IN	prep
Thomas	NNP	compound
Schnitzer	NNP	pobj
(	-LRB-	punct
"	``	punct
Schnitzer	NNP	dobj
"	''	punct
)	-RRB-	punct
speculate	VBG	xcomp
that	IN	mark
the	DT	det
failure	NN	nsubj
of	IN	prep
the	DT	det
Recker	NNP	compound
study	NN	pobj
be	VBD	ccomp
due	JJ	acomp
to	IN	prep
the	DT	det
long	JJ	amod
dose	NN	npadvmod
-	HYPH	punct
free	JJ	amod
interval	NN	pobj
.	.	punct

 	_SP	

the	DT	det
Recker	NNP	compound
study	NN	nsubj
,	,	punct
however	RB	advmod
,	,	punct
show	VBD	ROOT
a	DT	det
26	CD	nummod
%	NN	compound
reduction	NN	dobj
in	IN	prep
vertebral	JJ	amod
fracture	NNS	pobj
with	IN	prep
intravenous	JJ	amod
ibandronate	NN	pobj
administer	VBN	acl
once	RB	advmod
every	DT	det
three	CD	nummod
month	NNS	npadvmod
.	.	punct

the	DT	det
study	NN	nsubj
be	VBD	ROOT
a	DT	det
"	``	punct
failure	NN	attr
"	''	punct
only	RB	advmod
in	IN	prep
the	DT	det
sense	NN	pobj
that	IN	mark
the	DT	det
26	CD	nummod
%	NN	compound
reduction	NN	nsubj
be	VBD	acl
statistically	RB	advmod
insignificant	JJ	acomp
give	VBN	prep
the	DT	det
large	JJ	amod
number	NN	pobj
of	IN	prep
patient	NNS	pobj
that	WDT	nsubjpass
would	MD	aux
have	VB	aux
be	VBN	auxpass
require	VBN	relcl
to	TO	aux
reach	VB	xcomp
a	DT	det
statistically	RB	advmod
significant	JJ	amod
conclusion	NN	dobj
about	IN	prep
the	DT	det
relative	JJ	amod
rate	NNS	pobj
of	IN	prep
fracture	NNS	pobj
in	IN	prep
the	DT	det
control	NN	nmod
and	CC	cc
subject	JJ	conj
group	NNS	pobj
.	.	punct

With	IN	prep
respect	NN	pobj
to	IN	prep
the	DT	det
reduction	NN	pobj
of	IN	prep
hip	NN	compound
fracture	NNS	pobj
,	,	punct
for	IN	prep
example	NN	pobj
,	,	punct
Recker	NNP	nsubj
conclude	VBD	ROOT
that	IN	mark
"	``	punct
a	DT	det
meaningful	JJ	amod
conclusion	NN	nsubjpass
with	IN	prep
regard	NN	pobj
to	IN	prep
efficacy	NN	pobj
could	MD	aux
not	RB	neg
be	VB	auxpass
make	VBN	ccomp
owe	VBG	oprd
to	IN	prep
the	DT	det
low	JJ	amod
absolute	JJ	amod
number	NN	pobj
of	IN	prep
hip	NN	compound
fracture	NNS	pobj
"	''	punct
.	.	punct

Recker	NNP	poss
's	POS	case
failure	NN	ccomp
to	TO	aux
generate	VB	acl
statistically	RB	advmod
significant	JJ	amod
result	NNS	compound
point	NNS	dobj
to	IN	prep
a	DT	det
fault	NN	pobj
in	IN	prep
the	DT	det
study	NN	pobj
;	:	punct
-PRON-	PRP	nsubj
do	VBZ	aux
not	RB	neg
teach	VB	ROOT
that	DT	det
infrequent	NN	amod
ibandronate	NN	compound
dose	VBG	dobj
be	VBZ	ccomp
ineffective	JJ	acomp
in	IN	prep
treat	VBG	pcomp
osteoporosis	NN	dobj
.	.	punct

 	_SP	

the	DT	det
prior	JJ	amod
art	NN	compound
reference	NNS	nsubj
that	WDT	nsubj
interpret	VBD	relcl
Recker	NNP	poss
's	POS	case
result	NNS	dobj
demonstrate	VBP	ROOT
only	RB	advmod
that	IN	mark
-PRON-	PRP	nsubj
be	VBD	ccomp
unknown	JJ	acomp
why	WRB	advmod
Recker	NNP	nsubj
be	VBD	ccomp
unsuccessful	JJ	acomp
in	IN	prep
demonstrate	VBG	pcomp
statistically	RB	advmod
significant	JJ	amod
antifracture	NN	compound
efficacy	NN	dobj
.	.	punct

Schnitzer	NNP	nsubj
speculate	VBD	ROOT
that	IN	mark
the	DT	det
long	JJ	amod
drug	NN	npadvmod
-	HYPH	punct
free	JJ	amod
interval	NN	nsubj
be	VBD	ccomp
to	TO	aux
blame	VB	xcomp
for	IN	prep
the	DT	det
inconclusive	JJ	amod
result	NNS	pobj
and	CC	cc
that	IN	mark
dose	VBG	amod
interval	NNS	nsubj
longer	RBR	advmod
than	IN	prep
one	CD	nummod
or	CC	cc
two	CD	conj
week	NNS	pobj
would	MD	aux
be	VB	conj
ineffective	JJ	acomp
.	.	punct

On	IN	prep
the	DT	det
other	JJ	amod
hand	NN	pobj
,	,	punct
an	DT	det
article	NN	nsubj
by	IN	prep
Dr.	NNP	compound
Dennis	NNP	compound
Black	NNP	pobj
(	-LRB-	punct
"	``	punct
Black	NNP	appos
"	''	punct
)	-RRB-	punct
describe	VBD	ROOT
speculation	NN	dobj
that	IN	mark
the	DT	det
dos	NNS	nsubj
use	VBN	acl
in	IN	prep
Recker	NNP	pobj
be	VBD	acl
too	RB	advmod
low	JJ	acomp
.	.	punct

In	IN	prep
fact	NN	pobj
,	,	punct
Roche	NNP	nsubj
-PRON-	PRP	appos
subsequently	RB	advmod
acknowledge	VBD	ROOT
that	IN	mark
the	DT	det
Recker	NNP	compound
study	NN	nsubjpass
be	VBD	auxpass
underdosed	JJ	ccomp
.	.	punct

thus	RB	advmod
,	,	punct
Schnitzer	NNP	poss
's	POS	case
speculation	NN	nsubj
do	VBD	aux
not	RB	neg
amount	VB	ROOT
to	IN	prep
an	DT	det
affirmative	JJ	amod
teaching	NN	pobj
away	RB	advmod
from	IN	prep
monthly	JJ	amod
oral	JJ	amod
dosing	NN	pobj
of	IN	prep
ibandronate	NN	pobj
,	,	punct
especially	RB	advmod
in	IN	prep
the	DT	det
face	NN	pobj
of	IN	prep
Black	NNP	poss
's	POS	case
compete	VBG	amod
explanation	NN	pobj
of	IN	prep
the	DT	det
Recker	NNP	compound
result	NNS	pobj
.	.	punct

 	_SP	

any	DT	det
doubt	NN	nsubjpass
about	IN	prep
the	DT	det
efficacy	NN	pobj
of	IN	prep
oral	JJ	amod
ibandronate	NN	compound
dose	VBG	pobj
that	WDT	nsubjpass
may	MD	aux
have	VB	aux
be	VBN	auxpass
create	VBN	relcl
by	IN	agent
Schnitzer	NNP	poss
's	POS	case
speculation	NN	pobj
be	VBD	auxpass
put	VBN	ROOT
to	IN	aux
rest	NN	advcl
by	IN	prep
an	DT	det
article	NN	pobj
publish	VBN	acl
in	IN	prep
2001	CD	pobj
by	IN	agent
Riis	NNP	compound
et	NNP	compound
al	NNP	pobj
.	.	punct

entitle	VBN	ROOT
Ibandronate	NNP	oprd
:	:	punct

a	DT	det
Comparison	NNP	ROOT
of	IN	prep
Oral	NNP	compound
Daily	NNP	compound
dose	VBG	compound
Versus	NNP	compound
Intermittent	NNP	compound
dose	VBG	pobj
in	IN	prep
Postmenopausal	NNP	compound
Osteoporosis	NNP	pobj
(	-LRB-	punct
"	``	punct
rii	NNS	appos
"	''	punct
)	-RRB-	punct
.	.	punct

rii	NNS	nsubj
demonstrate	VBD	ROOT
that	IN	mark
"	``	punct
intermittent	JJ	amod
ibandronate	NN	nsubj
be	VBZ	ccomp
as	RB	advmod
effective	JJ	acomp
as	IN	prep
the	DT	det
continuous	JJ	amod
treatment	NN	pobj
in	IN	prep
term	NNS	pobj
of	IN	prep
significantly	RB	advmod
increase	VBG	pcomp

BMD	NNP	ROOT
at	IN	prep
the	DT	det
spine	NN	pobj
and	CC	cc
hip	NN	conj
and	CC	cc
suppress	VBG	conj
marker	NNS	dobj
of	IN	prep
bone	NN	compound
turnover	NN	pobj
"	''	punct
.	.	punct

rii	NNS	nsubj
show	VBD	ROOT
that	IN	mark
increase	NNS	nsubjpass
in	IN	prep
BMD	NNP	amod
equivalent	JJ	pobj
to	IN	prep
those	DT	pobj
obtain	VBN	acl
with	IN	prep
a	DT	det
2.5	CD	nummod
mg	NN	pobj
per	IN	prep
day	NN	pobj
treatment	NN	compound
regiman	NNS	nsubjpass
be	VBD	auxpass
obtain	VBN	ccomp
with	IN	prep
a	DT	det
regimen	NN	pobj
of	IN	prep
20	CD	nummod
mg	NN	pobj
of	IN	prep
ibandronate	NN	pobj
every	DT	det
other	JJ	amod
day	NN	npadvmod
for	IN	prep
the	DT	det
first	JJ	amod
24	CD	nummod
day	NNS	pobj
of	IN	prep
every	DT	det
three	CD	nummod
-	HYPH	punct
month	NN	compound
period	NN	pobj
.	.	punct

Those	DT	det
result	NNS	nsubj
,	,	punct
Riis	NNP	nsubj
conclude	VBD	parataxis
,	,	punct
"	''	punct
confirm	VBD	ROOT
preclinical	JJ	amod
datum	NNS	dobj
show	VBG	acl
that	IN	mark
-PRON-	PRP	nsubj
be	VBZ	ccomp
the	DT	det
total	JJ	amod
dose	NN	attr
over	IN	prep
a	DT	det
predefined	JJ	amod
period	NN	pobj
and	CC	cc
not	RB	neg
the	DT	det
dosing	JJ	amod
regimen	NNS	conj
that	WDT	nsubj
be	VBZ	relcl
the	DT	det
determine	VBG	amod
factor	NN	attr
for	IN	prep
effect	NN	pobj
on	IN	prep
bone	NN	compound
mass	NN	pobj
and	CC	cc
architecture	NN	conj
after	IN	prep
ibandronate	NN	pcomp
treatment	NN	dobj
"	''	punct
.	.	punct

Riis	NNP	poss
's	POS	case
teaching	NN	nsubj
that	IN	mark
a	DT	det
dose	NN	npadvmod
-	HYPH	punct
free	JJ	amod
interval	NN	nsubj
of	IN	prep
more	JJR	amod
than	IN	quantmod
two	CD	nummod
month	NNS	pobj
do	VBD	aux
not	RB	neg
impact	VB	ccomp
the	DT	det
BMD	NNP	amod
efficacy	NN	dobj
of	IN	prep
ibandronate	NN	pobj
be	VBD	ROOT
directly	RB	advmod
contrary	JJ	acomp
to	IN	prep
Schnitzer	NNP	poss
's	POS	case
speculation	NN	pobj
that	IN	mark
such	PDT	predet
a	DT	det
dosing	JJ	amod
regimen	NN	nsubj
would	MD	aux
not	RB	neg
be	VB	acl
effective	JJ	acomp
.	.	punct

therefore	RB	advmod
,	,	punct
even	RB	advmod
if	IN	mark
Schnitzer	NNP	poss
's	POS	case
interpretation	NN	nsubjpass
of	IN	prep
the	DT	det
Recker	NNP	compound
study	NN	pobj
be	VBD	auxpass
view	VBN	advcl
as	IN	prep
teach	VBG	pcomp
away	RB	advmod
from	IN	prep
monthly	JJ	amod
dosing	NN	pobj
,	,	punct
Riis	NNP	poss
's	POS	case
contrary	JJ	amod
finding	NNS	nsubj
substantially	RB	advmod
undermine	VBD	ROOT
that	DT	det
interpretation	NN	dobj
.	.	punct

 	_SP	

Roche	NNP	nsubj
argue	VBZ	ROOT
that	IN	mark
Riis	NNP	nsubj
do	VBD	aux
not	RB	neg
overcome	VB	ccomp
Schnitzer	NNP	poss
's	POS	case
interpretation	NN	dobj
because	IN	mark
Riis	NNP	nsubj
be	VBD	advcl
not	RB	neg
an	DT	det
antifracture	NN	compound
trial	NN	attr
.	.	punct

Roche	NNP	nsubj
argue	VBZ	ROOT
that	IN	mark
prior	JJ	amod
art	NN	nsubj
focus	VBG	acl
only	RB	advmod
on	IN	prep
BMD	NNP	amod
and	CC	cc
bone	NN	compound
-	HYPH	punct
turnover	NN	conj
improvement	NNS	pobj
,	,	punct
instead	RB	advmod
of	IN	cc
on	IN	prep
antifracture	NN	compound
efficacy	NN	pobj
,	,	punct
do	VBZ	aux
not	RB	neg
bear	VB	ccomp
on	IN	prep
the	DT	det
obviousness	JJ	amod
analysis	NN	pobj
in	IN	prep
this	DT	det
case	NN	pobj
because	IN	mark
such	JJ	amod
prior	JJ	amod
art	NN	nsubj
do	VBZ	aux
not	RB	neg
establish	VB	advcl
a	DT	det
reasonable	JJ	amod
expectation	NN	dobj
of	IN	prep
success	NN	pobj
in	IN	prep
reduce	VBG	pcomp
fracture	NN	compound
risk	NN	dobj
.	.	punct

 	_SP	

While	IN	mark
-PRON-	PRP	nsubj
be	VBZ	advcl
true	JJ	acomp
that	IN	mark
BMD	NNP	amod
improvement	NNS	nsubj
do	VBP	aux
not	RB	neg
perfectly	RB	advmod
correlate	VB	ccomp
with	IN	prep
antifracture	NN	compound
efficacy	NN	pobj
,	,	punct
-PRON-	PRP	nsubjpass
be	VBD	auxpass
well	RB	advmod
establish	VBN	ROOT
in	IN	prep
the	DT	det
art	NN	pobj
that	WDT	mark
BMD	NNP	nsubj
be	VBZ	relcl
a	DT	det
powerful	JJ	amod
surrogate	NN	attr
for	IN	prep
measure	VBG	pcomp
fracture	NN	amod
risk	NN	dobj
.	.	punct

For	IN	prep
example	NN	pobj
,	,	punct
Roche	NNP	poss
's	POS	case
own	JJ	amod
expert	NN	nsubj
explain	VBD	ROOT
:	:	punct

 	_SP	

Bone	NNP	compound
mineral	NN	compound
density	NN	nsubjpass
be	VBZ	auxpass
directly	RB	advmod
relate	VBN	ROOT
to	IN	prep
fracture	VB	amod
risk	NN	pobj
.	.	punct

-PRON-	PRP	nsubj
be	VBZ	ROOT
one	CD	attr
of	IN	prep
the	DT	det
most	RBS	advmod
powerful	JJ	amod
surrogate	JJ	compound
marker	NNS	pobj
in	IN	prep
the	DT	det
field	NN	pobj
of	IN	prep
medicine	NN	pobj
.	.	punct

-PRON-	PRP	nsubj
be	VBZ	ROOT
as	RB	advmod
powerful	JJ	amod
an	DT	det
indicator	NN	nsubj
of	IN	prep
osteoporosis	NN	pobj
as	IN	prep
blood	NN	compound
pressure	NN	pobj
be	VBZ	ccomp
a	DT	det
predictor	NN	attr
of	IN	prep
stroke	NN	pobj
.	.	punct

For	IN	prep
every	DT	det
standard	JJ	amod
deviation	NN	compound
reduction	NN	pobj
in	IN	prep
bone	NN	compound
mineral	NN	compound
density	NN	pobj
,	,	punct
fracture	NN	amod
risk	NN	nsubjpass
be	VBZ	auxpass
double	VBN	ROOT
.	.	punct

 	_SP	

Roche	NNP	poss
's	POS	case
patent	NNS	nsubj
do	VBP	aux
not	RB	neg
-PRON-	PRP	dobj
present	JJ	amod
datum	NNS	compound
demonstrate	VBG	ROOT
antifracture	NN	compound
efficacy	NN	dobj
for	IN	prep
a	DT	det
once	RB	advmod
monthly	JJ	amod
150	CD	nummod
mg	NN	compound
dose	NN	pobj
.	.	punct

In	IN	prep
fact	NN	pobj
,	,	punct
antifracture	NN	compound
efficacy	NN	nsubjpass
for	IN	prep
Boniva	NNP	pobj
(r)	SYM	intj
be	VBD	auxpass
demonstrate	VBN	ROOT
to	IN	prep
the	DT	det
FDA	NNP	pobj
through	IN	prep
a	DT	det
"	``	punct
bridge	VBG	amod
study	NN	pobj
"	''	punct
that	WDT	nsubj
use	VBD	relcl
BMD	NNP	dobj
and	CC	cc
bone	NN	conj
turnover	NN	compound
result	NNS	dobj
-	,	punct
not	RB	neg
antifracture	NN	compound
testing	NN	dobj
-	:	punct
to	TO	aux
establish	VB	xcomp
the	DT	det
therapeutic	JJ	amod
noninferiority	NN	dobj
of	IN	prep
the	DT	det
150	CD	nummod
mg	NN	nmod
monthly	JJ	amod
dose	NN	pobj
relative	JJ	amod
to	IN	prep
the	DT	det
previously	RB	advmod
approve	VBN	amod
2.5	CD	nummod
mg	NN	nmod
daily	JJ	amod
dose	NN	pobj
,	,	punct
for	IN	prep
which	WDT	pobj
antifracture	NN	compound
efficacy	NN	nsubjpass
have	VBD	aux
be	VBN	auxpass
demonstrate	VBN	relcl
.	.	punct

  	_SP	

conclusive	JJ	amod
proof	NN	nsubj
of	IN	prep
efficacy	NN	pobj
be	VBZ	ROOT
not	RB	neg
necessary	JJ	acomp
to	TO	aux
show	VB	xcomp
obviousness	JJ	dobj
.	.	punct

all	DT	nsubj
that	WDT	nsubjpass
be	VBZ	auxpass
require	VBN	relcl
be	VBZ	ROOT
a	DT	det
reasonable	JJ	amod
expectation	NN	attr
of	IN	prep
success	NN	pobj
.	.	punct

see	VB	ROOT
PharmaStem	NNP	compound
Therapeutics	NNP	dobj
,	,	punct
Inc.	NNP	appos
v.	IN	prep
ViaCell	NNP	pobj
,	,	punct
Inc.	NNP	appos
,	,	punct
491	CD	nummod
f.3d	CD	appos
1342	CD	nummod
,	,	punct
1363	CD	npadvmod
-	SYM	punct
64	CD	prep
(	-LRB-	punct
Fed	NNP	nmod
.	.	punct
cir.2007	ADD	npadvmod
)	-RRB-	punct
;	:	punct
Pfizer	NNP	npadvmod
,	,	punct
Inc.	NNP	appos
v.	CC	prep
Apotex	NNP	pobj
,	,	punct
Inc.	NNP	appos
,	,	punct
480	CD	nummod
f.3d	CD	appos
1348	CD	appos
,	,	punct
1364	CD	npadvmod
(	-LRB-	punct
Fed	NNP	nmod
.	.	punct
cir.2007	ADD	appos
)	-RRB-	punct
.	.	punct

rii	NNS	ROOT
-	,	punct
along	IN	prep
with	IN	prep
other	JJ	amod
prior	JJ	amod
art	NN	pobj
that	WDT	nsubj
use	VBD	relcl
BMD	NNP	amod
improvement	NN	dobj
as	IN	prep
the	DT	det
primary	JJ	amod
efficacy	NN	compound
marker	NN	pobj
for	IN	prep
treat	VBG	pcomp
osteoporosis	NN	npadvmod
-	HYPH	punct
establish	VBN	amod
at	IN	advmod
least	JJS	advmod
a	DT	det
reasonable	JJ	amod
expectation	NN	dobj
that	IN	mark
once	RB	advmod
monthly	JJ	amod
dosing	NN	nsubj
of	IN	prep
ibandronate	NN	pobj
could	MD	aux
successfully	RB	advmod
treat	VB	relcl
osteoporosis	NN	dobj
and	CC	cc
reduce	VB	conj
fracture	NN	amod
risk	NN	dobj
.	.	punct

 	_SP	

B.	NNP	compound
select	VBG	ROOT
the	DT	det
150	CD	nummod
mg	NN	compound
Dose	NNP	dobj

 	_SP	
1	CD	nummod
.	.	punct

rii	NNS	nsubj
confirm	VBD	ROOT
the	DT	det
total	JJ	amod
-	HYPH	punct
dose	NN	compound
concept	NN	dobj
whereby	IN	advmod
"	``	punct
the	DT	det
efficacy	NN	nsubj
of	IN	prep
ibandronate	NN	pobj
depend	VBZ	advcl
on	IN	prep
the	DT	det
total	JJ	amod
oral	JJ	amod
dose	NN	pobj
give	VBN	acl
rather	RB	advmod
than	IN	prep
on	IN	prep
the	DT	det
dosing	JJ	amod
schedule	NN	pobj
"	''	punct
.	.	punct

rii	NNS	nsubj
therefore	RB	advmod
teach	VBZ	ROOT
that	IN	mark
in	IN	prep
set	VBG	pcomp
the	DT	det
dosage	NN	compound
level	NN	dobj
for	IN	prep
an	DT	det
intermittent	JJ	amod
ibandronate	NN	compound
regimen	NN	pobj
,	,	punct
one	PRP	nsubj
nee	MD	ccomp
only	RB	advmod
scale	VB	dobj
up	RP	prt
a	DT	det
know	VBN	amod
-	HYPH	punct
effective	JJ	amod
dose	NN	dobj
from	IN	prep
a	DT	det
short	JJ	amod
-	HYPH	punct
interval	JJ	compound
regimen	NN	pobj
-	:	punct
e.g	NN	subtok
.	.	pobj
,	,	punct
daily	RB	amod
dosing	NN	appos
-	:	punct
to	TO	aux
achieve	VB	advcl
approximately	RB	advmod
the	DT	det
same	JJ	amod
bmd	NN	nmod
and	CC	cc
bone	NN	compound
-	HYPH	punct
loss	NN	conj
efficacy	NN	dobj
with	IN	prep
a	DT	det
long	JJ	amod
-	HYPH	punct
interval	JJ	amod
regimen	NN	pobj
.	.	punct

 	_SP	

the	DT	det
prior	JJ	amod
art	NN	nsubj
provide	VBD	ROOT
substantial	JJ	amod
guidance	NN	dobj
as	IN	prep
to	IN	prep
the	DT	det
total	JJ	amod
dose	NN	pobj
,	,	punct
within	IN	prep
a	DT	det
give	VBN	amod
time	NN	compound
period	NN	pobj
,	,	punct
that	WDT	nsubj
would	MD	aux
produce	VB	conj
effective	JJ	amod
result	NNS	dobj
.	.	punct

a	DT	det
1996	CD	nummod
article	NN	nsubj
by	IN	prep
Ravn	NNP	compound
et	NNP	compound
al	NNP	pobj
.	.	punct
(	-LRB-	punct
"	``	punct
Ravn	NNP	appos
"	''	punct
)	-RRB-	punct
report	VBD	ROOT
the	DT	det
result	NNS	dobj
of	IN	prep
a	DT	det
study	NN	pobj
that	WDT	nsubj
measure	VBD	relcl
BMD	NNP	amod
improvement	NNS	dobj
and	CC	cc
bone	NN	compound
-	HYPH	punct
turnover	NN	compound
marker	NNS	conj
for	IN	prep
daily	JJ	amod
ibandronate	NN	amod
dos	NNS	pobj
of	IN	prep
0.25	CD	nummod
mg	NN	pobj
,	,	punct
0.5	CD	nummod
mg	NN	appos
,	,	punct
1.0	CD	nummod
mg	NN	appos
,	,	punct
2.5	CD	nummod
mg	NN	conj
,	,	punct
and	CC	cc
5	CD	nummod
mg	NN	conj
.	.	punct

the	DT	det
author	NNS	nsubj
conclude	VBD	ROOT
that	IN	mark
the	DT	det
"	``	punct
average	JJ	amod
change	NN	nsubj
in	IN	prep
bone	NN	compound
mass	NN	pobj
show	VBD	ccomp
positive	JJ	amod
outcome	NN	dobj
in	IN	prep
all	DT	det
region	NNS	pobj
in	IN	prep
the	DT	det
group	NNS	pobj
receive	VBG	acl
ibandronate	VB	acl
2.5	CD	dobj
and	CC	cc
5.0	CD	nummod
mg	NN	conj
"	''	punct
.	.	punct

the	DT	det
2.5	CD	nummod
mg	NN	compound
dose	NN	nsubj
exhibit	VBD	ROOT
a	DT	det
response	NN	dobj
that	WDT	nsubj
be	VBD	relcl
"	``	punct
virtually	RB	advmod
equal	JJ	acomp
"	''	punct
to	IN	prep
the	DT	det
5	CD	nummod
mg	NN	compound
dose	NN	pobj
,	,	punct
even	RB	advmod
though	IN	mark
-PRON-	PRP	nsubj
contain	VBD	advcl
only	RB	advmod
half	PDT	nummod
the	DT	det
amount	NN	dobj
of	IN	prep
ibandronate	NN	pobj
.	.	punct

the	DT	det
2.5	CD	nummod
mg	NN	compound
dose	NN	nsubjpass
be	VBD	auxpass
thereby	RB	advmod
deem	VBN	ROOT
the	DT	det
"	``	punct
most	RBS	advmod
effective	JJ	amod
dose	NN	oprd
"	''	punct
.	.	punct

 	_SP	

a	DT	det
person	NN	nsubjpass
skilled	JJ	amod
in	IN	prep
the	DT	det
art	NN	pobj
look	VBG	acl
to	TO	aux
scale	VB	xcomp
to	IN	prep
a	DT	det
monthly	JJ	amod
dose	NN	pobj
of	IN	prep
oral	JJ	amod
ibandronate	NN	pobj
from	IN	prep
a	DT	det
know	VBN	amod
-	HYPH	punct
effective	JJ	amod
daily	JJ	amod
dose	NN	pobj
be	VBD	auxpass
thus	RB	advmod
face	VBN	ccomp
with	IN	prep
a	DT	det
very	RB	advmod
limited	JJ	amod
set	NN	pobj
of	IN	prep
possibility	NNS	pobj
:	:	punct
Of	IN	prep
the	DT	det
five	CD	nummod
daily	JJ	amod
dos	NNS	pobj
test	VBN	acl
in	IN	prep
Ravn	NNP	pobj
,	,	punct
only	RB	advmod
the	DT	det
2.5	CD	nummod
and	CC	cc
5	CD	conj
mg	NN	conj
dos	NNS	nsubj
"	''	punct
show	VBD	ROOT
positive	JJ	amod
outcome	NN	dobj
in	IN	prep
all	DT	det
region	NNS	pobj
"	''	punct
.	.	punct

even	RB	advmod
though	IN	mark
the	DT	det
5	CD	nummod
mg	NN	compound
dose	NN	nsubj
do	VBD	aux
not	RB	neg
demonstrate	VB	advcl
great	JJR	amod
efficacy	NN	dobj
than	IN	prep
the	DT	det
2.5	CD	nummod
mg	NN	compound
dose	NN	pobj
,	,	punct
-PRON-	PRP	nsubjpass
be	VBD	auxpass
still	RB	advmod
deem	VBN	ROOT
an	DT	det
equivalently	RB	advmod
effective	JJ	amod
dose	NN	oprd
so	IN	mark
that	IN	mark
someone	NN	nsubj
scale	VBG	acl
-PRON-	PRP	dobj
to	IN	prep
a	DT	det
single	JJ	amod
monthly	JJ	amod
dose	NN	pobj
of	IN	prep
150	CD	nummod
mg	NN	pobj
(	-LRB-	punct
5	CD	nummod
mg	NN	nmod
/	SYM	punct
day	NN	nmod
x	SYM	punct
30	CD	nummod
day	NNS	nmod
/	SYM	punct
month	NN	appos
)	-RRB-	punct
would	MD	aux
have	VB	aux
anticipate	VBN	advcl
equivalent	JJ	amod
success	NN	dobj
in	IN	prep
raise	VBG	pcomp
BMD	NNP	dobj
and	CC	cc
limit	VBG	conj
bone	NN	compound
turnover	NN	dobj
,	,	punct
base	VBN	prep
on	IN	prep
Riis	NNP	pobj
.	.	punct

 	_SP	

additionally	RB	advmod
,	,	punct
United	NNP	compound
States	NNP	compound
Patent	NNP	compound
No.	SYM	nsubj
6,432,932	CD	nummod
(	-LRB-	punct
"	``	punct
Daifotis	NNP	appos
"	''	punct
)	-RRB-	punct
disclose	VBD	ROOT
weekly	JJ	amod
dos	NNS	dobj
of	IN	prep
ibandronate	NN	pobj
"	''	punct
from	IN	prep
the	DT	det
group	NN	pobj
consist	VBG	acl
of	IN	prep
35	CD	nummod
mg	NN	pobj
,	,	punct
40	CD	nummod
mg	NN	appos
,	,	punct
45	CD	nummod
mg	NN	conj
,	,	punct
or	CC	cc
50	CD	nummod
mg	NN	conj
"	''	punct
.	.	punct

the	DT	det
35	CD	nummod
mg	NN	nmod
weekly	JJ	amod
dose	NN	nsubj
correspond	NNS	ROOT
to	IN	prep
the	DT	det
same	JJ	amod
total	JJ	amod
dose	NN	pobj
as	IN	prep
a	DT	det
5	CD	nummod
mg	NN	nmod
daily	JJ	amod
dose	NN	pobj
.	.	punct

the	DT	det
total	JJ	amod
-	HYPH	punct
dose	NN	compound
equivalent	NN	nsubj
to	IN	prep
5	CD	nummod
mg	NN	pobj
of	IN	prep
ibandronate	NN	pobj
per	IN	prep
day	NN	pobj
be	VBZ	ROOT
thus	RB	advmod
the	DT	det
only	JJ	amod
dose	NN	attr
that	WDT	nsubj
appear	VBZ	relcl
in	IN	prep
both	CC	preconj
Ravn	NNP	pobj
and	CC	cc
Daifotis	NNP	conj
-	HYPH	punct
suggest	VBG	acl
that	IN	mark
there	EX	expl
be	VBD	ccomp
a	DT	det
reasonable	JJ	amod
expectation	NN	attr
of	IN	prep
success	NN	pobj
with	IN	prep
the	DT	det
total	JJ	amod
-	HYPH	punct
dose	NN	compound
equivalent	NNS	pobj
of	IN	prep
the	DT	det
5	CD	nummod
mg	NN	nmod
daily	JJ	amod
dose	NN	pobj
,	,	punct
i.e.	FW	advmod
,	,	punct
150	CD	nummod
mg	NN	appos
per	IN	prep
month	NN	pobj
.	.	punct

 	_SP	

accordingly	RB	advmod
,	,	punct
the	DT	det
prior	JJ	amod
art	NN	nsubj
point	VBD	ROOT
to	IN	prep
a	DT	det
monthly	JJ	amod
treatment	NN	pobj
of	IN	prep
150	CD	nummod
mg	NN	pobj
of	IN	prep
ibandronate	NN	pobj
.	.	punct

At	IN	prep
the	DT	det
very	RB	advmod
least	JJS	pobj
,	,	punct
the	DT	det
150	CD	nummod
mg	NN	compound
dose	NN	nsubj
be	VBD	ccomp
obvious	JJ	acomp
to	TO	aux
try	VB	xcomp
:	:	punct
there	EX	expl
be	VBD	ROOT
a	DT	det
need	NN	attr
to	TO	aux
solve	VB	acl
the	DT	det
problem	NN	dobj
of	IN	prep
patient	JJ	amod
compliance	NN	pobj
by	IN	prep
look	VBG	pcomp
to	IN	prep
less	RBR	advmod
-	HYPH	punct
frequent	JJ	amod
dosing	NN	amod
regimen	NNS	pobj
.	.	punct

and	CC	cc
,	,	punct
base	VBN	prep
on	IN	prep
Ravn	NNP	pobj
and	CC	cc
Daifotis	NNP	conj
,	,	punct
in	IN	prep
light	NN	pobj
of	IN	prep
Riis	NNP	poss
's	POS	case
total	JJ	amod
-	HYPH	punct
dose	NN	compound
concept	NN	pobj
,	,	punct
there	EX	expl
be	VBD	ROOT
only	RB	advmod
a	DT	det
"	``	punct
finite	JJ	amod
number	NN	attr
of	IN	prep
identify	VBN	amod
,	,	punct
predictable	JJ	amod
solution	NNS	pobj
"	''	punct
.	.	punct

KSR	NNP	subtok
Int'l	NNP	compound
Co.	NNP	ROOT
v.	IN	prep
Teleflex	NNP	pobj
,	,	punct
550	CD	nummod
U.S.	NNP	appos
398	CD	nummod
,	,	punct
421	CD	nummod
,	,	punct
127	CD	nummod
S.Ct	NNP	subtok
.	.	punct

1727	CD	ROOT
,	,	punct
167	CD	nummod
l.ed.2d	NN	appos
705	CD	nummod
(	-LRB-	punct
2007	CD	npadvmod
)	-RRB-	punct
.	.	punct

 	_SP	

2	CD	ROOT
.	.	punct

Roche	NNP	nsubj
contend	VBZ	ROOT
that	IN	mark
finding	NNS	nsubj
by	IN	prep
the	DT	det
FDA	NNP	pobj
teach	VBD	ccomp
away	RB	advmod
from	IN	prep
further	JJ	amod
development	NN	pobj
of	IN	prep
the	DT	det
5	CD	nummod
mg	NN	nmod
daily	JJ	amod
dose	NN	pobj
(	-LRB-	punct
and	CC	cc
-PRON-	PRP$	poss
total	JJ	amod
-	HYPH	punct
dose	NN	compound
equivalent	NNS	conj
)	-RRB-	punct
because	IN	mark
the	DT	det
FDA	NNP	nsubj
approve	VBD	advcl
a	DT	det
2.5	CD	nummod
mg	NN	nmod
daily	JJ	amod
dose	NN	dobj
of	IN	prep
ibandronate	NN	pobj
instead	RB	advmod
of	IN	cc
a	DT	det
5	CD	nummod
mg	NN	nmod
daily	JJ	amod
dose	NN	pobj
.	.	punct

but	CC	cc
the	DT	det
FDA	NNP	nsubj
never	RB	neg
make	VBD	ROOT
any	DT	det
finding	NNS	nsubj
contrary	JJ	ccomp
to	IN	prep
the	DT	det
5	CD	nummod
mg	NN	nmod
daily	JJ	amod
dose	NN	pobj
,	,	punct
because	IN	mark
-PRON-	PRP	nsubjpass
be	VBD	auxpass
never	RB	neg
ask	VBN	advcl
to	TO	aux
approve	VB	xcomp
that	DT	det
dose	NN	dobj
.	.	punct

instead	RB	advmod
,	,	punct
in	IN	prep
approve	VBG	pcomp
the	DT	det
2.5	CD	nummod
mg	NN	nmod
daily	JJ	amod
dose	NN	dobj
,	,	punct
the	DT	det
FDA	NNP	nsubj
merely	RB	advmod
restate	VBD	ROOT
the	DT	det
result	NNS	dobj
of	IN	prep
Ravn	NNP	pobj
and	CC	cc
conclude	VBD	conj
that	IN	mark
"	``	punct
the	DT	det
2.5	CD	nummod
mg	NN	nmod
daily	JJ	amod
dose	NN	nsubj
of	IN	prep
ibandronate	NN	pobj
have	VBZ	ccomp
the	DT	det
most	RBS	advmod
favorable	JJ	amod
benefit	NN	compound
-	HYPH	punct
risk	NN	compound
ratio	NN	dobj
and	CC	cc
be	VBZ	conj
the	DT	det
most	RBS	advmod
appropriate	JJ	amod
dose	NN	attr
for	IN	prep
the	DT	det
prevention	NN	pobj
and	CC	cc
treatment	NN	conj
of	IN	prep
postmenopausal	NN	amod
osteoporosis	NN	pobj
"	''	punct
.	.	punct

 	_SP	

Roche	NNP	nsubj
next	RB	advmod
contend	VBZ	ROOT
that	IN	mark
Schofield	NNP	nsubj
teach	VBD	ccomp
away	RB	advmod
from	IN	prep
use	VBG	pcomp
anything	NN	dobj
other	JJ	amod
than	IN	prep
the	DT	det
low	JJS	amod
effective	JJ	amod
dose	NN	pobj
of	IN	prep
a	DT	det
bisphosphonate	NN	pobj
,	,	punct
which	WDT	nsubjpass
,	,	punct
accord	VBG	prep
to	IN	prep
Roche	NNP	pobj
,	,	punct
be	VBD	auxpass
establish	VBN	relcl
by	IN	agent
Ravn	NNP	pobj
to	TO	aux
be	VB	advcl
2.5	CD	nummod
mg	NN	attr
for	IN	prep
ibandronate	NN	pobj
.	.	punct

Schofield	NNP	nsubj
,	,	punct
however	RB	advmod
,	,	punct
do	VBZ	aux
not	RB	neg
teach	VB	ROOT
that	IN	mark
the	DT	det
low	JJS	amod
effective	JJ	amod
dose	NN	nsubj
be	VBZ	ccomp
the	DT	det
only	JJ	amod
dose	NN	attr
that	WDT	nsubjpass
should	MD	aux
be	VB	auxpass
use	VBN	relcl
when	WRB	advmod
treat	VBG	advcl
osteoporosis	NN	dobj
with	IN	prep
a	DT	det
bisphosphonate	NN	pobj
.	.	punct

instead	RB	advmod
,	,	punct
Schofield	NNP	nsubj
merely	RB	advmod
define	VBD	ROOT
the	DT	det
low	JJS	amod
effective	JJ	amod
dose	NN	dobj
as	IN	prep
a	DT	det
measure	NN	pobj
of	IN	prep
a	DT	det
drug	NN	poss
's	POS	case
potency	NN	pobj
relative	JJ	advmod
to	IN	prep
-PRON-	PRP$	poss
therapeutic	JJ	amod
effect	NNS	pobj
.	.	punct

Schofield	NNP	nsubj
then	RB	advmod
describe	VBD	ROOT
a	DT	det
preferred	JJ	amod
embodiment	NN	dobj
of	IN	prep
a	DT	det
method	NN	pobj
for	IN	prep
treat	VBG	pcomp
bone	NN	compound
disorder	NNS	dobj
in	IN	prep
which	WDT	pobj
the	DT	det
maintenance	NN	compound
dose	NN	nsubj
of	IN	prep
a	DT	det
"	``	punct
bone	NN	npadvmod
-	HYPH	punct
active	JJ	amod
phosphonate	NN	pobj
"	''	punct
range	VBN	relcl
from	IN	prep
2.5	CD	quantmod
to	TO	quantmod
15	CD	nummod
mg	NN	pobj
per	IN	prep
day	NN	pobj
.	.	punct

that	DT	det
range	NN	nsubj
clearly	RB	advmod
encompass	VBZ	ROOT
more	JJR	dobj
than	IN	prep
just	RB	advmod
a	DT	det
low	JJS	amod
effective	JJ	amod
dose	NN	pobj
.	.	punct

moreover	RB	advmod
,	,	punct
Ravn	NNP	nsubj
never	RB	neg
purport	VBD	ROOT
to	TO	aux
establish	VB	xcomp
a	DT	det
low	JJS	amod
effective	JJ	amod
dose	NN	dobj
.	.	punct

instead	RB	advmod
,	,	punct
-PRON-	PRP	nsubj
seek	VBD	ROOT
to	TO	aux
establish	VB	xcomp
a	DT	det
"	``	punct
most	RBS	advmod
effective	JJ	amod
[	-LRB-	punct
daily	RB	amod
]	-RRB-	punct
dose	NN	dobj
"	''	punct
.	.	punct

 	_SP	

Roche	NNP	nsubj
argue	VBZ	ROOT
that	IN	mark
the	DT	det
district	NN	compound
court	NN	nsubj
misinterpret	VBD	ccomp
and	CC	cc
misapply	VBD	conj
the	DT	det
total	JJ	amod
-	HYPH	punct
dose	NN	compound
concept	NN	dobj
from	IN	prep
Riis	NNP	pobj
.	.	punct

accord	VBG	prep
to	IN	prep
Roche	NNP	pobj
,	,	punct
the	DT	det
district	NN	compound
court	NN	nsubj
"	''	punct
take	VBD	ROOT
a	DT	det
technical	JJ	amod
leap	NN	dobj
"	''	punct
in	IN	prep
find	VBG	pcomp
that	IN	mark
Riis	NNP	poss
's	POS	case
total	JJ	amod
-	HYPH	punct
dose	NN	compound
concept	NN	nsubj
imply	VBN	ccomp
only	RB	advmod
simple	JJ	amod
multiplication	NN	dobj
to	TO	aux
scale	VB	acl
from	IN	prep
an	DT	det
efficacious	JJ	amod
daily	JJ	amod
dose	NN	pobj
to	IN	prep
a	DT	det
monthly	JJ	amod
dose	NN	pobj
.	.	punct

the	DT	det
evidence	NN	nsubj
before	IN	prep
the	DT	det
district	NN	compound
court	NN	pobj
,	,	punct
however	RB	advmod
,	,	punct
show	VBD	ROOT
that	IN	mark
the	DT	det
total	JJ	amod
-	HYPH	punct
dose	NN	compound
concept	NN	nsubjpass
can	MD	aux
be	VB	auxpass
use	VBN	ccomp
as	IN	prep
an	DT	det
effective	JJ	amod
rule	NN	pobj
of	IN	prep
thumb	NN	pobj
by	IN	agent
a	DT	det
person	NN	pobj
skilled	JJ	amod
in	IN	prep
the	DT	det
art	NN	pobj
decide	VBG	acl
how	WRB	advmod
to	TO	aux
scale	VB	xcomp
to	IN	prep
an	DT	det
efficacious	JJ	amod
intermittent	JJ	amod
dose	NN	pobj
of	IN	prep
ibandronate	NN	pobj
.	.	punct

the	DT	det
Riis	NNPS	compound
study	NN	nsubj
,	,	punct
in	IN	prep
particular	JJ	amod
,	,	punct
establish	VBD	ROOT
that	IN	mark
the	DT	det
total	JJ	amod
dose	NN	compound
concept	NN	nsubj
can	MD	aux
reliably	RB	advmod
predict	VB	ccomp
that	IN	mark
the	DT	det
efficacy	NN	nsubj
of	IN	prep
an	DT	det
ibandronate	JJ	amod
treatment	NN	pobj
depend	VBZ	ccomp
on	IN	prep
the	DT	det
total	JJ	amod
dose	NN	pobj
administer	VBD	acl
to	IN	prep
a	DT	det
patient	NN	pobj
over	IN	prep
a	DT	det
give	VBN	amod
period	NN	pobj
,	,	punct
not	RB	neg
on	IN	prep
the	DT	det
amount	NN	pobj
administer	VBN	acl
at	IN	prep
any	DT	det
single	JJ	amod
point	NN	pobj
in	IN	prep
time	NN	pobj
.	.	punct

In	IN	prep
light	NN	pobj
of	IN	prep
that	DT	det
evidence	NN	pobj
,	,	punct
-PRON-	PRP	nsubj
be	VBD	ROOT
reasonable	JJ	acomp
to	TO	aux
expect	VB	xcomp
that	IN	mark
a	DT	det
once	RB	advmod
monthly	JJ	amod
dose	NN	nsubj
of	IN	prep
150	CD	nummod
mg	NN	pobj
would	MD	aux
have	VB	ccomp
roughly	RB	advmod
the	DT	det
same	JJ	amod
efficacy	NN	dobj
as	IN	prep
a	DT	det
daily	JJ	amod
dose	NN	pobj
of	IN	prep
5	CD	nummod
mg	NN	pobj
.	.	punct

 	_SP	

C.	NNP	compound
Safety	NNP	nsubj
of	IN	prep
the	DT	det
150	CD	nummod
mg	NN	nmod
Dose	NNP	nmod

 	_SP	
Roche	NNP	pobj
next	RB	advmod
contend	VBZ	ROOT
that	IN	mark
there	EX	expl
be	VBP	ccomp
dispute	VBN	amod
issue	NNS	attr
of	IN	prep
fact	NN	pobj
as	IN	prep
to	IN	prep
whether	IN	mark
-PRON-	PRP	nsubj
would	MD	aux
have	VB	aux
be	VBN	pcomp
obvious	JJ	acomp
to	TO	aux
administer	VB	xcomp
once	RB	advmod
monthly	JJ	amod
dos	NNS	dobj
of	IN	prep
150	CD	nummod
mg	NN	pobj
in	IN	prep
light	NN	pobj
of	IN	prep
allege	VBN	amod
safety	NN	compound
concern	NNS	pobj
about	IN	prep
the	DT	det
adverse	JJ	amod
gastrointestinal	JJ	amod
effect	NNS	pobj
of	IN	prep
ibandronate	NN	pobj
and	CC	cc
other	JJ	amod
bisphosphonate	NNS	conj
.	.	punct

 	_SP	

first	RB	advmod
,	,	punct
Roche	NNP	nsubj
argue	VBZ	ROOT
that	IN	mark
Ravn	NNP	nsubj
teach	VBD	ccomp
away	RB	advmod
from	IN	prep
further	JJ	amod
development	NN	pobj
of	IN	prep
the	DT	det
5	CD	nummod
mg	NN	nmod
daily	JJ	amod
dose	NN	pobj
,	,	punct
and	CC	cc
thereby	RB	advmod
-PRON-	PRP$	poss
total	JJ	amod
-	HYPH	punct
dose	NN	compound
equivalent	NNS	conj
,	,	punct
because	IN	mark
Ravn	NNP	nsubj
teach	VBD	advcl
that	IN	mark
the	DT	det
2.5	CD	nummod
mg	NN	nmod
daily	JJ	amod
dose	NN	nsubj
be	VBD	ccomp
more	RBR	advmod
effective	JJ	acomp
than	IN	prep
the	DT	det
5	CD	nummod
mg	NN	nmod
daily	JJ	amod
dose	NN	pobj
and	CC	cc
have	VBD	conj
few	JJR	amod
side	NN	compound
effect	NNS	dobj
.	.	punct

Ravn	NNP	nsubj
,	,	punct
however	RB	advmod
,	,	punct
conclude	VBD	ROOT
that	IN	punct
"	``	punct
the	DT	det
response	NNS	pobj
in	IN	prep
the	DT	det
group	NNS	pobj
receive	VBG	acl

2.5	CD	nummod
and	CC	cc
5	CD	conj
mg	NN	compound
ibandronate	NN	nsubj
be	VBD	ROOT
virtually	RB	advmod
equal	JJ	acomp
,	,	punct
"	''	punct
not	RB	neg
that	IN	mark
the	DT	det
2.5	CD	nummod
mg	NN	compound
dose	NN	nsubj
be	VBD	conj
more	RBR	advmod
effective	JJ	acomp
.	.	punct

and	CC	cc
although	IN	mark
patient	NNS	nsubj
on	IN	prep
the	DT	det
5	CD	nummod
mg	NN	nmod
daily	JJ	amod
dose	NN	pobj
drop	VBD	advcl
out	IN	prep
of	IN	prep
the	DT	det
study	NN	pobj
at	IN	prep
a	DT	det
high	JJR	amod
rate	NN	pobj
than	IN	prep
patient	NNS	pobj
on	IN	prep
low	JJR	amod
dos	NNS	pobj
,	,	punct
Ravn	NNP	nsubj
do	VBD	aux
not	RB	neg
conclude	VB	ROOT
that	IN	mark
the	DT	det
high	JJR	amod
drop	NN	nmod
-	HYPH	punct
out	RP	prt
rate	NN	nsubj
be	VBD	ccomp
statistically	RB	advmod
significant	JJ	acomp
.	.	punct

instead	RB	advmod
,	,	punct
the	DT	det
author	NNS	nsubj
merely	RB	advmod
note	VBD	ROOT
that	IN	mark
a	DT	det
high	JJR	amod
frequency	NN	nsubjpass
of	IN	prep
diarrhea	NN	pobj
be	VBD	auxpass
experience	VBN	ccomp
with	IN	prep
the	DT	det
5	CD	nummod
mg	NN	compound
dose	NN	pobj
.	.	punct

a	DT	det
high	JJR	amod
frequency	NN	nsubj
of	IN	prep
diarrhea	NN	pobj
do	VBZ	aux
not	RB	neg
necessarily	RB	advmod
teach	VB	ROOT
away	RB	advmod
from	IN	prep
the	DT	det
5	CD	nummod
mg	NN	nmod
daily	JJ	amod
dose	NN	pobj
or	CC	cc
-PRON-	PRP$	poss
equivalent	NNS	conj
,	,	punct
however	RB	advmod
,	,	punct
as	IN	mark
the	DT	det
prior	JJ	amod
art	NN	nsubj
indicate	VBD	advcl
that	IN	mark
modest	JJ	amod
gastrointestinal	JJ	amod
side	NN	compound
effect	NNS	nsubjpass
must	MD	aux
be	VB	auxpass
weigh	VBN	ccomp
in	IN	prep
light	NN	pobj
of	IN	prep
the	DT	det
benefit	NNS	pobj
of	IN	prep
the	DT	det
drug	NN	pobj
.	.	punct

indeed	RB	advmod
,	,	punct
Ravn	NNP	nsubj
-PRON-	PRP	appos
conclude	VBD	ROOT
that	IN	mark
"	``	punct
in	IN	prep
the	DT	det
present	JJ	amod
study	NN	pobj
,	,	punct
the	DT	det
side	NN	compound
effect	NN	compound
profile	NN	nsubj
of	IN	prep
ibandronate	NN	pobj
seem	VBD	ccomp
to	TO	aux
be	VB	xcomp
safe	JJ	acomp
"	''	punct
and	CC	cc
that	IN	mark
"	``	punct
in	IN	prep
general	JJ	amod
,	,	punct
the	DT	det
safety	NN	compound
evaluation	NN	nsubj
do	VBD	aux
not	RB	neg
reveal	VB	conj
any	DT	det
difference	NNS	nsubj
between	IN	prep
ibandronate	NN	pobj
and	CC	cc
placebo	NN	conj
treated	JJ	ccomp
group	NNS	dobj
"	''	punct
.	.	punct

 	_SP	

moreover	RB	advmod
,	,	punct
even	RB	advmod
if	IN	mark
the	DT	det
high	JJR	amod
incidence	NN	nsubj
of	IN	prep
diarrhea	NN	pobj
and	CC	cc
the	DT	det
large	JJR	amod
number	NN	conj
of	IN	prep
dropout	NNS	pobj
in	IN	prep
the	DT	det
Ravn	NNP	compound
study	NN	pobj
be	VBD	advcl
initially	RB	advmod
enough	JJ	acomp
to	TO	aux
teach	VB	xcomp
away	RB	advmod
from	IN	prep
further	JJ	amod
development	NN	pobj
of	IN	prep
the	DT	det
5	CD	nummod
mg	NN	nmod
daily	JJ	amod
dose	NN	pobj
and	CC	cc
-PRON-	PRP$	poss
total	JJ	amod
dose	NN	compound
equivalent	NNS	conj
,	,	punct
any	DT	det
such	JJ	amod
teaching	NN	nsubjpass
away	RB	advmod
would	MD	aux
have	VB	aux
be	VBN	auxpass
overcome	VBN	ROOT
by	IN	agent
Riis	NNP	poss
's	POS	case
find	VBG	pobj
that	IN	mark
an	DT	det
oral	JJ	amod
administration	NN	nsubj
of	IN	prep
20	CD	nummod
mg	NN	pobj
of	IN	prep
ibandronate	NN	pobj
every	DT	det
other	JJ	amod
day	NN	appos
for	IN	prep
24	CD	nummod
day	NNS	pobj
,	,	punct
follow	VBN	acl
by	IN	agent
a	DT	det
nine	CD	nummod
-	HYPH	punct
week	NN	compound
rest	NN	compound
phase	NN	pobj
,	,	punct
result	VBD	acl
in	IN	prep
the	DT	det
same	JJ	amod
rate	NN	pobj
of	IN	prep
side	NN	compound
effect	NNS	pobj
as	IN	prep
a	DT	det
2.5	CD	nummod
mg	NN	nmod
daily	JJ	amod
regiman	NNS	pobj
.	.	punct

 	_SP	

aside	RB	advmod
from	IN	prep
Ravn	NNP	pobj
,	,	punct
Roche	NNP	nsubj
do	VBZ	aux
not	RB	neg
point	VB	ROOT
to	IN	prep
any	DT	det
reference	NNS	pobj
suggest	VBG	acl
that	IN	mark
there	EX	expl
be	VBD	ccomp
safety	NN	compound
concern	NNS	attr
associate	VBN	acl
with	IN	prep
the	DT	det
150	CD	nummod
mg	NN	compound
dose	NN	pobj
.	.	punct

nor	CC	cc
be	VBD	ROOT
Roche	NNP	poss
's	POS	case
expert	NN	attr
,	,	punct
Dr.	NNP	compound
Harris	NNP	appos
,	,	punct
aware	JJ	appos
of	IN	prep
anything	NN	pobj
that	WDT	nsubj
teach	VBD	relcl
that	IN	mark
a	DT	det
once	RB	advmod
monthly	JJ	pobj
,	,	punct
150	CD	nummod
mg	NN	compound
dose	NN	nsubj
of	IN	prep
ibandronate	NN	pobj
would	MD	aux
be	VB	ccomp
unsafe	JJ	acomp
.	.	punct

 	_SP	

To	IN	prep
the	DT	det
contrary	NN	pobj
,	,	punct
the	DT	det
prior	JJ	amod
art	NN	nsubj
establish	VBZ	nsubjpass
that	WDT	nsubj
dose	VBZ	ccomp
even	RB	advmod
high	JJR	advmod
than	IN	prep
150	CD	nummod
mg	NN	pobj
be	VBD	auxpass
consider	VBN	ROOT
safe	JJ	oprd
.	.	punct

United	NNP	compound
States	NNP	compound
Patent	NNP	compound
No.	SYM	compound
6,143,326	CD	nsubj
(	-LRB-	punct
"	``	punct
Mockel	NNP	appos
"	''	punct
)	-RRB-	punct
state	VBD	ROOT
that	IN	mark
rapid	JJ	amod
-	HYPH	punct
release	NN	compound
ibandronate	NN	compound
formulation	NNS	nsubj
show	VBD	ccomp
"	``	punct
no	DT	det
significant	JJ	amod
side	NN	compound
effect	NNS	dobj
...	NFP	punct
in	IN	prep
clinical	JJ	amod
study	NNS	pobj
use	VBG	acl
ibandronate	VBP	dobj
even	RB	advmod
at	IN	prep
high	JJ	amod
dosage	NNS	pobj
"	''	punct
and	CC	cc
disclose	VBD	conj
single	JJ	amod
-	HYPH	punct
dose	NN	compound
unit	NNS	dobj
up	IN	quantmod
to	IN	quantmod
250	CD	nummod
mg	NN	dobj
.	.	punct

defendant	NNS	poss
'	POS	case
expert	NN	nsubj
,	,	punct
Dr.	NNP	compound
Yates	NNP	appos
,	,	punct
testify	VBD	ROOT
that	IN	mark
the	DT	det
disclosure	NNS	nsubj
in	IN	prep
Mockel	NNP	pobj
would	MD	aux
have	VB	aux
lead	VBN	ccomp
a	DT	det
person	NN	dobj
of	IN	prep
ordinary	JJ	amod
skill	NN	pobj
in	IN	prep
the	DT	det
art	NN	pobj
to	TO	aux
understand	VB	advcl
that	DT	nsubj
ibandronate	NN	ccomp
dose	VBZ	dobj
up	IN	quantmod
to	IN	quantmod
250	CD	nummod
mg	NN	dobj
would	MD	aux
be	VB	auxpass
well	RB	advmod
tolerate	VBN	ccomp
.	.	punct

likewise	RB	advmod
,	,	punct
Daifotis	NNP	nsubj
disclose	VBD	ROOT
that	IN	mark
"	``	punct
for	IN	prep
human	JJ	amod
oral	JJ	amod
composition	NNS	compound
comprising	NN	compound
ibandronate	NN	pobj
...	:	punct
a	DT	det
unit	NN	compound
dosage	NN	nsubj
typically	RB	advmod
comprise	VBZ	ccomp
from	IN	prep
about	RB	advmod
3.5	CD	nummod
mg	NN	pobj
to	IN	prep
about	RB	advmod
200	CD	nummod
mg	NN	pobj
of	IN	prep
the	DT	det
ibandronate	NN	compound
compound	NN	pobj
"	''	punct
.	.	punct

 	_SP	

there	EX	expl
be	VBZ	ROOT
thus	RB	advmod
no	DT	det
genuine	JJ	amod
issue	NN	attr
of	IN	prep
fact	NN	pobj
concern	VBG	acl
whether	IN	mark
the	DT	det
prior	JJ	amod
art	NN	nsubj
teach	VBD	ccomp
away	RB	advmod
from	IN	prep
the	DT	det
150	CD	nummod
mg	NN	compound
dose	NN	pobj
base	VBN	acl
on	IN	prep
safety	NN	compound
concern	NNS	pobj
.	.	punct

 	_SP	

D.	NNP	compound
Unexpected	NNP	compound
Results	NNP	ROOT

 	_SP	

Roche	NNP	nsubj
argue	VBZ	ROOT
that	IN	mark
the	DT	det
district	NN	compound
court	NN	nsubj
err	VBD	ccomp
by	IN	prep
grant	VBG	pcomp
summary	JJ	amod
judgment	NN	dobj
of	IN	prep
obviousness	NN	pobj
because	IN	mark
the	DT	det
evidence	NN	nsubj
of	IN	prep
record	NN	pobj
show	VBD	advcl
that	IN	mark
the	DT	det
150	CD	nummod
mg	NN	nmod
monthly	JJ	amod
dose	NN	nsubj
be	VBD	ccomp
more	RBR	advmod
effective	JJ	acomp
than	IN	prep
the	DT	det
2.5	CD	nummod
mg	NN	nmod
daily	JJ	amod
dose	NN	pobj
and	CC	cc
that	IN	mark
the	DT	det
superior	JJ	amod
effectiveness	NN	nsubj
of	IN	prep
the	DT	det
150	CD	nummod
mg	NN	nmod
monthly	JJ	amod
dose	NN	pobj
be	VBD	conj
unexpected	JJ	acomp
.	.	punct

Roche	NNP	nsubj
also	RB	advmod
contend	VBZ	ROOT
that	DT	mark
ibandronate	NN	poss
's	POS	case
nonlinear	JJ	amod
bioavailability	NN	nsubj
at	IN	prep
the	DT	det
150	CD	nummod
mg	NN	compound
dosage	NN	compound
level	NN	pobj
be	VBD	ccomp
an	DT	det
unexpected	JJ	amod
result	NN	attr
.	.	punct

 	_SP	

Roche	NNP	poss
's	POS	case
MOBILE	NNP	compound
study	NN	nsubj
,	,	punct
publish	VBN	acl
in	IN	prep
2005	CD	pobj
,	,	punct
demonstrate	VBD	ROOT
that	IN	mark
a	DT	det
150	CD	nummod
mg	NN	nmod
monthly	JJ	amod
dose	NN	nsubj
be	VBZ	ccomp
more	RBR	advmod
effective	JJ	acomp
than	IN	prep
a	DT	det
2.5	CD	nummod
mg	NN	nmod
daily	JJ	amod
dose	NN	pobj
with	IN	prep
respect	NN	pobj
to	IN	prep
BMD	NNP	amod
improvement	NN	pobj
in	IN	prep
the	DT	det
lumbar	JJ	compound
spine	NN	pobj
and	CC	cc
most	JJS	amod
hip	NN	compound
site	NNS	conj
.	.	punct

the	DT	det
MOBILE	NNP	compound
study	NN	nsubj
demonstrate	VBD	ROOT
,	,	punct
for	IN	prep
example	NN	pobj
,	,	punct
a	DT	det
mean	JJ	amod
BMD	NNP	amod
improvement	NN	dobj
in	IN	prep
the	DT	det
lumbar	JJ	compound
spine	NN	pobj
of	IN	prep
4.9	CD	nummod
%	NN	pobj
after	IN	prep
one	CD	nummod
year	NN	pobj
for	IN	prep
patient	NNS	pobj
take	VBG	acl
the	DT	det
150	CD	nummod
mg	NN	nmod
monthly	JJ	amod
dose	NN	dobj
and	CC	cc
3.9	CD	nummod
%	NN	conj
after	IN	prep
one	CD	nummod
year	NN	pobj
for	IN	prep
patient	NNS	pobj
take	VBG	acl
the	DT	det
2.5	CD	nummod
mg	NN	nmod
daily	JJ	amod
dose	NN	dobj
.	.	punct

another	DT	det
study	NN	nsubj
publish	VBN	acl
in	IN	prep
2005	CD	pobj
show	VBD	ROOT
that	IN	mark
the	DT	det
extent	NN	nsubj
of	IN	prep
ibandronate	NN	poss
's	POS	case
bioavailability	NN	pobj
be	VBZ	ccomp
nonlinear	JJ	acomp
with	IN	prep
increase	VBG	amod
dosage	NNS	pobj
:	:	punct
increase	VBG	advcl
the	DT	det
oral	JJ	amod
dose	NN	dobj
by	IN	prep
50	CD	nummod
percent	NN	pobj
,	,	punct
from	IN	prep
100	CD	nummod
mg	NN	pobj
to	IN	prep
150	CD	nummod
mg	NN	pobj
,	,	punct
result	VBD	dep
in	IN	prep
a	DT	det
nearly	RB	advmod
150	CD	nummod
percent	NN	compound
increase	NN	pobj
in	IN	prep
the	DT	det
amount	NN	pobj
of	IN	prep
the	DT	det
drug	NN	pobj
absorb	VBN	acl
by	IN	agent
the	DT	det
blood	NN	pobj
.	.	punct

 	_SP	

While	IN	mark
the	DT	det
evidence	NN	nsubj
would	MD	aux
support	VB	advcl
a	DT	det
finding	NN	dobj
of	IN	prep
superior	JJ	amod
efficacy	NN	pobj
of	IN	prep
the	DT	det
150	CD	nummod
mg	NN	nmod
monthly	JJ	amod
dose	NN	pobj
in	IN	prep
raise	VBG	pcomp
BMD	NNP	amod
level	NNS	dobj
,	,	punct
as	IN	mark
compare	VBN	prep
to	IN	prep
a	DT	det
2.5	CD	nummod
mg	NN	nmod
daily	JJ	amod
dose	NN	pobj
,	,	punct
that	WDT	det
improve	VBD	amod
efficacy	NN	nsubj
do	VBZ	aux
not	RB	neg
rebut	VB	ROOT
the	DT	det
strong	JJ	amod
showing	NN	dobj
that	IN	mark
the	DT	det
prior	JJ	amod
art	NN	nsubj
disclose	VBD	acl
monthly	RB	amod
dosing	NN	dobj
and	CC	cc
that	IN	mark
there	EX	expl
be	VBD	conj
a	DT	det
reason	NN	attr
to	TO	aux
set	VB	relcl
that	DT	det
dose	NN	dobj
at	IN	prep
150	CD	nummod
mg	NN	pobj
.	.	punct

see	VB	ROOT

In	IN	ROOT
re	IN	pobj
Merck	NNP	pobj
&	CC	cc
Co.	NNP	conj
,	,	punct
800	CD	nummod
f.2d	CD	pobj
1091	CD	appos
,	,	punct
1099	CD	npadvmod
(	-LRB-	punct
Fed	NNP	nmod
.	.	punct
cir.1986	NN	appos
)	-RRB-	punct
.	.	punct

the	DT	det
evidence	NN	nsubj
of	IN	prep
superior	JJ	amod
efficacy	NN	pobj
do	VBZ	ROOT
nothing	NN	dobj
to	TO	aux
undercut	VB	relcl
the	DT	det
showing	NN	dobj
that	IN	mark
there	EX	expl
be	VBD	acl
a	DT	det
reasonable	JJ	amod
expectation	NN	attr
of	IN	prep
success	NN	pobj
with	IN	prep
the	DT	det
150	CD	nummod
mg	NN	nmod
monthly	JJ	amod
dose	NN	pobj
,	,	punct
even	RB	advmod
if	IN	mark
the	DT	det
level	NN	nsubj
of	IN	prep
success	NN	pobj
may	MD	aux
have	VB	aux
turn	VBN	advcl
out	RP	prt
to	TO	aux
be	VB	xcomp
somewhat	RB	advmod
great	JJR	acomp
than	IN	mark
would	MD	aux
have	VB	aux
be	VBN	auxpass
expect	VBN	advcl
.	.	punct

 	_SP	

For	IN	prep
the	DT	det
same	JJ	amod
reason	NNS	pobj
,	,	punct
the	DT	det
nonlinear	JJ	amod
bioavailability	NN	nsubj
of	IN	prep
ibandronate	NN	pobj
do	VBZ	aux
not	RB	neg
rebut	VB	ROOT
the	DT	det
prima	NN	amod
facie	NN	nsubj
showing	NN	dobj
of	IN	prep
obviousness	NN	pobj
of	IN	prep
a	DT	det
once	RB	advmod
monthly	JJ	amod
dose	NN	pobj
of	IN	prep
150	CD	nummod
mg	NN	pobj
.	.	punct

the	DT	det
increase	VBN	amod
level	NN	nsubjpass
of	IN	prep
bioavailability	NN	pobj
have	VBZ	aux
not	RB	neg
be	VBN	auxpass
show	VBN	ROOT
to	TO	aux
be	VB	xcomp
responsible	JJ	acomp
for	IN	prep
the	DT	det
improved	JJ	amod
osteoporosis	JJ	compound
treatment	NN	compound
efficacy	NN	pobj
of	IN	prep
the	DT	det
150	CD	nummod
mg	NN	compound
dose	NN	pobj
.	.	punct

a	DT	det
study	NN	nsubj
by	IN	prep
Ravn	NNP	compound
et	NNP	compound
al	NNP	pobj
.	.	punct
in	IN	prep
2002	CD	pobj
show	VBD	ROOT
,	,	punct
for	IN	prep
example	NN	pobj
,	,	punct
that	IN	mark
a	DT	det
near	JJ	amod
doubling	NN	nsubj
of	IN	prep
the	DT	det
blood	NN	compound
-	HYPH	punct
serum	NN	compound
concentration	NN	pobj
of	IN	prep
ibandronate	NN	pobj
with	IN	prep
a	DT	det
5	CD	nummod
mg	NN	nmod
daily	JJ	amod
dose	NN	pobj
,	,	punct
compare	VBN	prep
to	IN	prep
a	DT	det
2.5	CD	nummod
mg	NN	nmod
daily	JJ	amod
dose	NN	pobj
,	,	punct
produce	VBD	ccomp
no	DT	det
further	JJ	amod
BMD	NNP	amod
increase	NN	dobj
and	CC	cc
no	DT	det
further	JJ	amod
reduction	NN	conj
in	IN	prep
bone	NN	compound
turnover	NN	pobj
.	.	punct

other	JJ	amod
record	NN	compound
evidence	NN	nsubj
confirm	VBZ	ROOT
that	IN	mark
"	``	punct
due	IN	prep
to	IN	pcomp
strong	JJ	amod
binding	NN	pobj
to	IN	prep
the	DT	det
bone	NN	compound
surface	NN	pobj
,	,	punct
the	DT	det
effect	NNS	nsubjpass
of	IN	prep
the	DT	det
systemically	RB	advmod
available	JJ	amod
amount	NN	pobj
of	IN	prep
a	DT	det
bisphosphonate	NN	pobj
be	VBP	auxpass
almost	RB	advmod
exclusively	RB	advmod
relate	VBN	ccomp
to	IN	prep
-PRON-	PRP$	poss
concentration	NN	pobj
in	IN	prep
bone	NN	pobj
rather	RB	advmod
than	IN	prep
[	-LRB-	punct
blood	NN	nmod
]	-RRB-	punct
serum	JJ	compound
level	NN	pobj
"	''	punct
.	.	punct

the	DT	det
evidence	NN	nsubj
regard	VBG	prep
bioavailability	NN	pobj
be	VBZ	ROOT
therefore	RB	advmod
of	IN	prep
little	JJ	amod
relevance	NN	pobj
to	IN	prep
the	DT	det
obviousness	JJ	amod
inquiry	NN	pobj
.	.	punct

 	_SP	

accordingly	RB	advmod
,	,	punct
-PRON-	PRP	nsubj
uphold	VBP	ROOT
the	DT	det
judgment	NN	dobj
of	IN	prep
the	DT	det
district	NN	compound
court	NN	pobj
that	WDT	nsubj
claim	VBZ	relcl
1	CD	npadvmod
-	SYM	punct
8	CD	prep
of	IN	prep
the	DT	det
¡¬634	NN	compound
patent	NN	pobj
and	CC	cc
claim	VBZ	conj
1	CD	npadvmod
-	SYM	punct
10	CD	prep
of	IN	prep
the	DT	det
¡¬957	JJ	compound
patent	NN	pobj
would	MD	aux
have	VB	aux
be	VBN	ccomp
obvious	JJ	acomp
in	IN	prep
light	NN	pobj
of	IN	prep
the	DT	det
prior	JJ	amod
art	NN	pobj
and	CC	cc
be	VBP	conj
therefore	RB	advmod
invalid	JJ	acomp
.	.	punct

 	_SP	

NEWMAN	NNP	ROOT
,	,	punct
Circuit	NNP	compound
Judge	NNP	npadvmod
,	,	punct
dissent	VBG	acl
.	.	punct

 	_SP	

Hoffmann	NNP	compound
-	HYPH	punct
LaRoche	NNP	nsubj
's	POS	case
once	RB	intj
-	HYPH	punct
a	DT	det
-	HYPH	punct
month	NN	npadvmod
Boniva	NNP	compound
(r)	SYM	npadvmod
ibandronate	VBP	ROOT
medication	NN	nsubj
for	IN	prep
osteoporosis	NN	pobj
require	VBN	ccomp
twelve	CD	nummod
year	NNS	dobj
of	IN	prep
research	NN	nmod
and	CC	cc
clinical	JJ	amod
testing	NN	pobj
and	CC	cc
evaluation	NN	conj
to	TO	aux
demonstrate	VB	advcl
-PRON-	PRP$	poss
efficacy	NN	dobj
when	WRB	advmod
dose	VBN	advcl
once	RB	advmod
a	DT	det
month	NN	npadvmod
and	CC	cc
-PRON-	PRP$	poss
safety	NN	conj
at	IN	prep
this	DT	det
high	JJ	amod
monthly	JJ	amod
dosage	NN	pobj
.	.	punct

the	DT	det
prior	JJ	amod
investigation	NNS	nsubj
of	IN	prep
intermittent	NN	amod
dosing	NN	pobj
,	,	punct
and	CC	cc
the	DT	det
publication	NNS	conj
describe	VBG	acl
proto	NN	compound
col	NNS	dobj
of	IN	prep
less	JJR	amod
success	NN	pobj
,	,	punct
miss	VBD	ROOT
the	DT	det
protocol	NN	dobj
that	WDT	nsubj
produce	VBD	relcl
this	DT	det
successful	JJ	amod
method	NN	dobj
.	.	punct

indeed	RB	advmod
,	,	punct
this	DT	det
prior	JJ	amod
art	NN	nsubj
weigh	VBZ	ccomp
heavily	RB	advmod
against	IN	prep
obviousness	JJ	pobj
,	,	punct
for	IN	prep
despite	IN	prep
extensive	JJ	amod
exploration	NN	pobj
,	,	punct
this	DT	det
successful	JJ	amod
protocol	NN	nsubjpass
be	VBD	auxpass
not	RB	neg
discover	VBN	ROOT
.	.	punct

 	_SP	

invalidation	NN	nsubjpass
of	IN	prep
this	DT	det
patent	NN	pobj
be	VBZ	auxpass
not	RB	neg
support	VBN	ROOT
by	IN	agent
clear	JJ	amod
and	CC	cc
convincing	JJ	conj
evidence	NN	pobj
.	.	punct

the	DT	det
court	NN	poss
's	POS	case
ruling	NN	nsubj
of	IN	prep
obviousness	JJ	pobj
violate	VBZ	ROOT
the	DT	det
principle	NNS	dobj
of	IN	prep
Graham	NNP	pobj
v.	CC	prep
John	NNP	compound
Deere	NNP	compound
Co.	NNP	conj
,	,	punct
383	CD	nummod
U.S.	NNP	npadvmod
1	CD	nummod
,	,	punct
86	CD	nummod
S.Ct	NNP	subtok
.	.	punct
684	CD	nummod
,	,	punct
15	CD	nummod
l.ed.2d	NN	nmod
545	CD	nummod
(	-LRB-	punct
1966	CD	appos
)	-RRB-	punct
(	-LRB-	punct
all	DT	det
factor	NNS	nsubjpass
must	MD	aux
be	VB	auxpass
consider	VBN	parataxis
,	,	punct
include	VBG	prep
commercial	JJ	amod
success	NN	pobj
,	,	punct
failure	NN	conj
of	IN	prep
other	NNS	pobj
,	,	punct
and	CC	cc
long	RB	advmod
-	HYPH	punct
feel	VBN	compound
need	NN	conj
)	-RRB-	punct
.	.	punct

the	DT	det
court	NN	poss
's	POS	case
reasoning	NN	nsubj
violate	VBZ	ROOT
the	DT	det
guidance	NN	dobj
of	IN	prep

KSR	NNP	compound
Int'l	NNP	compound
Co.	NNP	subtok
v.	CC	ROOT
Teleflex	NNP	compound
Inc.	NNP	pobj
,	,	punct
550	CD	nummod
U.S.	NNP	npadvmod
398	CD	nummod
,	,	punct
421	CD	nummod
,	,	punct
127	CD	nummod
S.Ct	NNP	subtok
.	.	npadvmod

1727	CD	nsubj
,	,	punct
167	CD	nummod
l.ed.2d	NN	appos
705	CD	nummod
(	-LRB-	punct
2007	CD	npadvmod
)	-RRB-	punct
(	-LRB-	punct
the	DT	det
standard	NN	nsubj
of	IN	prep
obvious	JJ	amod
-	HYPH	punct
to	TO	compound
-	HYPH	punct
try	VB	pobj
require	VBZ	ccomp
a	DT	det
limited	JJ	amod
number	NN	dobj
of	IN	prep
specify	VBN	amod
alternative	NNS	pobj
offer	VBG	acl
a	DT	det
likelihood	NN	dobj
of	IN	prep
success	NN	pobj
in	IN	prep
light	NN	pobj
of	IN	prep
the	DT	det
prior	JJ	amod
art	NN	pobj
and	CC	cc
common	JJ	amod
sense	NN	conj
)	-RRB-	punct
,	,	punct
this	DT	det
court	NN	nsubj
instead	RB	advmod
invoke	VBG	ROOT
judicial	JJ	amod
hindsight	NN	dobj
to	TO	aux
reconstruct	VB	acl
the	DT	det
patented	JJ	amod
subject	JJ	amod
matter	NN	dobj
.	.	punct

 	_SP	

nowhere	RB	advmod
amid	IN	prep
the	DT	det
many	JJ	amod
study	NNS	pobj
of	IN	prep
bisphosphonate	JJ	amod
osteoporosis	NN	compound
treatment	NNS	pobj
over	IN	prep
a	DT	det
wide	JJ	amod
range	NN	pobj
of	IN	prep
dosage	NNS	pobj
and	CC	cc
condition	NNS	conj
,	,	punct
do	VBD	ROOT
any	DT	det
reference	NN	compound
show	NN	dobj
or	CC	cc
suggest	VBP	conj
the	DT	det
Boniva	NNPS	compound
(r)	SYM	nmod
combination	NN	dobj
of	IN	prep
a	DT	det
single	JJ	amod
150	CD	nummod
mg	NN	compound
dose	NN	pobj
and	CC	cc
once	RB	advmod
-	HYPH	punct
a	DT	det
-	HYPH	punct
month	NN	pobj
administration	NN	conj
.	.	punct

no	DT	det
reference	NN	nsubj
suggest	VBD	ROOT
the	DT	det
effectiveness	NN	dobj
and	CC	cc
safety	NN	conj
of	IN	prep
this	DT	det
combination	NN	pobj
.	.	punct

nonetheless	RB	advmod
,	,	punct
-PRON-	PRP$	poss
colleague	NNS	nsubj
declare	VBP	ROOT
this	DT	det
treatment	NN	nsubj
obvious	JJ	ccomp
to	IN	prep
-PRON-	PRP	pobj
.	.	punct

-PRON-	PRP$	poss
colleague	NNS	poss
'	POS	case
primary	JJ	amod
reason	NN	nsubj
,	,	punct
that	IN	mark
150	CD	nummod
mg	NN	nsubj
be	VBZ	acl
thirty	CD	nummod
time	NNS	quantmod
the	DT	det
daily	JJ	amod
dose	NN	attr
of	IN	prep
5	CD	nummod
mg	NN	pobj
,	,	punct
do	VBZ	aux
not	RB	neg
mention	VB	ROOT
that	IN	mark
the	DT	det
FDA	NNP	nsubj
refuse	VBD	ccomp
to	TO	aux
approve	VB	xcomp
the	DT	det
5	CD	nummod
mg	NN	compound
dose	NN	dobj
due	IN	amod
to	IN	pcomp
-PRON-	PRP$	poss
toxic	JJ	amod
side	NN	compound
effect	NNS	pobj
.	.	punct

surely	RB	advmod
this	DT	nsubj
lead	VBZ	ROOT
away	RB	advmod
from	IN	prep
the	DT	det
obviousness	NN	pobj
of	IN	prep
a	DT	det
single	JJ	amod
dose	NN	pobj
thirty	CD	nummod
time	NNS	npadvmod
large	JJR	amod
.	.	punct

 	_SP	

-PRON-	PRP	nsubj
respectfully	RB	advmod
dissent	NN	ROOT
.	.	punct

 	_SP	

the	DT	det
unexpected	JJ	amod
result	NNS	nsubjpass
of	IN	prep
the	DT	det
patented	JJ	amod
method	NN	pobj
be	VBP	auxpass
concede	VBN	ROOT
by	IN	agent
the	DT	det
panel	NN	compound
majority	NN	pobj
.	.	punct

the	DT	det
evidence	NN	nsubj
on	IN	prep
summary	JJ	amod
judgment	NN	pobj
be	VBD	ROOT
that	IN	mark
many	JJ	amod
other	NNS	nsubj
seek	VBD	ccomp
and	CC	cc
fail	VBD	conj
to	TO	aux
find	VB	xcomp
an	DT	det
efficacious	JJ	amod
intermittent	JJ	amod
treatment	NN	compound
schedule	NN	dobj
.	.	punct

the	DT	det
prior	JJ	amod
art	NN	nsubj
rely	VBD	ROOT
on	RP	prt
by	IN	agent
-PRON-	PRP$	poss
colleague	NNS	pobj
surround	VBN	advcl
but	CC	cc
miss	VBD	conj
the	DT	det
Roche	NNP	compound
method	NN	dobj
.	.	punct

the	DT	det
prior	JJ	amod
art	NN	nsubj
show	VBZ	ROOT
that	IN	mark
safety	NN	nsubj
be	VBZ	ccomp
likely	JJ	acomp
to	TO	aux
be	VB	auxpass
compromise	VBN	xcomp
at	IN	prep
high	JJ	amod
dos	NNS	pobj
,	,	punct
and	CC	cc
that	IN	det
efficacy	NN	nsubj
be	VBZ	conj
likely	JJ	acomp
to	TO	aux
be	VB	auxpass
compromise	VBN	xcomp
at	IN	prep
extended	JJ	amod
dose	VBG	compound
interval	NNS	pobj
.	.	punct

nonetheless	RB	advmod
,	,	punct
this	DT	det
court	NN	nsubj
now	RB	advmod
hold	VBZ	ccomp
that	IN	mark
-PRON-	PRP	nsubj
be	VBD	ccomp
obvious	JJ	acomp
to	TO	aux
do	VB	xcomp
what	WP	dobj
no	DT	det
one	NN	nsubj
do	VBD	ccomp
or	CC	cc
even	RB	advmod
suggest	VBN	conj
;	:	punct
-PRON-	PRP$	poss
colleague	NNS	nsubj
simply	RB	advmod
disregard	VB	ROOT
the	DT	det
preference	NNS	dobj
and	CC	cc
toxicity	NN	compound
warning	NNS	conj
and	CC	cc
discard	VB	conj
the	DT	det
procedure	NNS	dobj
of	IN	prep
the	DT	det
prior	JJ	amod
art	NN	pobj
.	.	punct

 	_SP	

the	DT	det
prior	JJ	amod
art	NN	nsubj
show	VBZ	ROOT
intermittent	JJ	amod
therapy	NNS	dobj
range	VBG	acl
from	IN	prep
every	DT	det
other	JJ	amod
day	NN	pobj
to	IN	prep
once	RB	pcomp
a	DT	det
week	NN	npadvmod
to	TO	prep
twice	PDT	advmod
a	DT	det
week	NN	npadvmod
to	TO	prep
twice	PDT	pobj
a	DT	det
month	NN	npadvmod
to	IN	prep
every	DT	det
three	CD	nummod
month	NNS	pobj
plus	CC	cc
vary	VBG	conj
initial	JJ	amod
loading	NN	compound
period	NNS	dobj
,	,	punct
in	IN	prep
a	DT	det
wide	JJ	amod
range	NN	pobj
of	IN	prep
dosage	NNS	pobj
.	.	punct

the	DT	det
prior	JJ	amod
art	NN	nsubj
be	VBZ	ROOT
replete	JJ	acomp
with	IN	prep
warning	NNS	pobj
of	IN	prep
toxicity	NN	pobj
and	CC	cc
patient	JJ	amod
noncompliance	NN	conj
.	.	punct

the	DT	det
panel	NN	compound
majority	NN	nsubj
acknowledge	VBZ	ccomp
that	IN	mark
Roche	NNP	poss
's	POS	case
MOBILE	NNP	compound
study	NN	nsubj
and	CC	cc
the	DT	det
nonlinear	JJ	amod
bioavailability	NN	compound
datum	NNS	conj
(	-LRB-	punct
discuss	VBN	amod
infra	RB	appos
)	-RRB-	punct
demonstrate	VBP	ccomp
that	IN	mark
the	DT	det
150	CD	nummod
mg	NN	nmod
monthly	JJ	amod
treatment	NN	nsubj
produce	VBD	ccomp
unexpected	JJ	amod
result	NNS	dobj
,	,	punct
but	CC	cc
deem	VBZ	conj
this	DT	det
irrelevant	NN	dobj
;	:	punct
the	DT	det
court	NN	nsubj
now	RB	advmod
,	,	punct
with	IN	prep
knowledge	NN	pobj
of	IN	prep
Roche	NNP	poss
's	POS	case
success	NN	pobj
,	,	punct
deem	VBZ	ROOT
Roche	NNP	poss
's	POS	case
successful	JJ	amod
method	NN	nsubj
to	TO	aux
have	VB	aux
be	VBN	ccomp
obvious	JJ	acomp
all	RB	advmod
along	RB	advmod
.	.	punct

 	_SP	

the	DT	det
Supreme	NNP	compound
Court	NNP	nsubj
recognize	VBD	ROOT
in	IN	prep
KSR	NNP	pobj
that	IN	mark
a	DT	det
patent	NN	compound
challenger	NN	nsubj
must	MD	aux
"	``	punct
identify	VB	ccomp
a	DT	det
reason	NN	dobj
that	WDT	nsubj
would	MD	aux
have	VB	aux
prompt	VBN	relcl
a	DT	det
person	NN	dobj
of	IN	prep
ordinary	JJ	amod
skill	NN	pobj
in	IN	prep
the	DT	det
relevant	JJ	amod
field	NN	pobj
"	''	punct
to	TO	aux
arrive	VB	xcomp
at	IN	prep
the	DT	det
patented	JJ	amod
invention	NN	pobj
.	.	punct

550	CD	nummod
U.S.	NNP	ROOT
at	IN	prep
418	CD	pobj
,	,	punct
127	CD	nummod
S.Ct	NNP	subtok
.	.	punct
1727	CD	nummod
.	.	punct

-PRON-	PRP$	poss
colleague	NNS	nsubj
,	,	punct
unable	JJ	amod
to	TO	aux
find	VB	xcomp
any	DT	det
suggestion	NN	dobj
of	IN	prep
the	DT	det
Roche	NNP	compound
protocol	NN	pobj
in	IN	prep
the	DT	det
prior	JJ	amod
art	NN	pobj
,	,	punct
accept	VB	ROOT
the	DT	det
argument	NN	dobj
that	IN	mark
a	DT	det
monthly	JJ	amod
single	JJ	amod
dose	NN	nsubj
of	IN	prep
150	CD	nummod
mg	NN	pobj
be	VBD	acl
obvious	JJ	acomp
because	IN	mark
a	DT	det
monthly	JJ	amod
dose	NN	nsubj
of	IN	prep
150	CD	nummod
mg	NN	pobj
be	VBZ	advcl
thirty	CD	nummod
time	NNS	quantmod
a	DT	det
daily	JJ	amod
dose	NN	attr
of	IN	prep
5	CD	nummod
mg	NN	pobj
.	.	punct

the	DT	det
FDA	NNP	nsubj
have	VBD	aux
refuse	VBN	ROOT
to	TO	aux
approve	VB	xcomp
a	DT	det
daily	JJ	amod
dose	NN	dobj
of	IN	prep
5	CD	nummod
mg	NN	pobj
due	JJ	prep
to	IN	pcomp
-PRON-	PRP$	poss
demonstrate	VBN	amod
heightened	JJ	amod
toxicity	NN	pobj
.	.	punct

the	DT	det
success	NN	nsubjpass
of	IN	prep
a	DT	det
dose	NN	pobj
thirty	CD	nummod
time	NNS	npadvmod
large	JJR	amod
than	IN	prep
the	DT	det
prohibit	VBN	amod
5	CD	nummod
mg	NN	compound
dose	NN	pobj
can	MD	aux
not	RB	neg
reasonably	RB	advmod
be	VB	auxpass
predict	VBN	ROOT
.	.	punct

neither	CC	preconj
the	DT	det
prior	JJ	amod
art	NN	nsubj
,	,	punct
nor	CC	cc
common	JJ	amod
sense	NN	conj
,	,	punct
provide	VBZ	ROOT
the	DT	det
expectation	NN	dobj
that	IN	mark
a	DT	det
once	RB	amod
-	HYPH	punct
a	DT	det
-	HYPH	punct
month	NN	pobj
treatment	NN	nsubj
at	IN	prep
a	DT	det
dosage	NN	pobj
of	IN	prep
150	CD	nummod
mg	NN	pobj
would	MD	aux
be	VB	acl
safe	JJ	acomp
and	CC	cc
effective	JJ	conj
.	.	punct

 	_SP	

a.	NN	ROOT

the	DT	det
Prior	NNP	compound
Art	NNP	ROOT

 	_SP	
1	CD	nummod
.	.	punct

the	DT	det
Mockel	NNP	compound
Patent	NNP	ROOT

 	_SP	

-PRON-	PRP$	poss
colleague	NNS	nsubj
combine	VBP	ROOT
many	JJ	amod
reference	NNS	dobj
to	TO	aux
support	VB	advcl
-PRON-	PRP$	poss
ruling	NN	dobj
of	IN	prep
obviousness	NN	pobj
.	.	punct

-PRON-	PRP	nsubj
cite	VBP	ROOT
the	DT	det
Mockel	NNP	compound
patent1	NN	dobj
for	IN	prep
the	DT	det
proposition	NN	pobj
that	WDT	mark
single	JJ	amod
dos	NNS	nsubjpass
of	IN	prep
more	JJR	amod
than	IN	quantmod
150	CD	nummod
mg	NN	pobj
be	VBD	auxpass
"	``	punct
know	VBN	acl
"	''	punct
.	.	punct

Mockel	NNP	nsubjpass
be	VBZ	auxpass
direct	VBN	ROOT
to	IN	aux
coated	JJ	xcomp
tablet	NN	compound
formulation	NNS	dobj
,	,	punct
not	RB	neg
the	DT	det
concentration	NN	appos
of	IN	prep
active	JJ	amod
ingredient	NNS	pobj
.	.	punct

Mockel	NNP	nsubj
provide	VBZ	ROOT
specific	JJ	amod
example	NNS	dobj
of	IN	prep
ibandronate	NN	compound
tablet	NNS	pobj
contain	VBG	acl
a	DT	det
maximum	JJ	amod
dose	NN	dobj
of	IN	prep
50	CD	nummod
mg	NN	pobj
,	,	punct
state	VBZ	conj
that	IN	mark
the	DT	det
prefer	VBN	amod
upper	JJ	amod
limit	NN	nsubj
be	VBZ	ccomp
100	CD	nummod
mg	NN	attr
,	,	punct
and	CC	cc
that	IN	mark
the	DT	det
formulation	NNS	nsubj
could	MD	aux
contain	VB	conj
up	RP	prt
to	IN	prep
about	IN	advmod
250	CD	nummod
mg	NN	pobj
.	.	punct

Mockel	NNP	nsubj
show	VBZ	ROOT
no	DT	det
formulated	JJ	amod
dose	NN	dobj
large	JJR	amod
than	IN	prep
50	CD	nummod
mg	NN	pobj
,	,	punct
although	IN	mark
the	DT	det
reference	NN	nsubj
contain	VBZ	advcl
the	DT	det
usual	JJ	amod
expansive	JJ	amod
statement	NNS	dobj
of	IN	prep
the	DT	det
patent	NN	compound
scrivener	NN	pobj
.	.	punct

 	_SP	

Mockel	NNP	nsubj
state	VBZ	ROOT
that	IN	mark
"	``	punct
no	DT	det
significant	JJ	amod
side	NN	compound
effect	NNS	nsubjpass
be	VBD	auxpass
observe	VBN	ccomp
in	IN	prep
clinical	JJ	amod
study	NNS	pobj
use	VBG	acl
ibandronate	NN	dobj
at	IN	prep
high	JJ	amod
dosage	NNS	pobj
,	,	punct
"	''	punct
but	CC	cc
do	VBZ	aux
not	RB	neg
state	VB	conj
that	IN	mark
"	``	punct
high	JJ	amod
"	''	punct
exceed	VBZ	ccomp
-PRON-	PRP$	poss
prefer	VBN	amod
upper	JJ	amod
limit	NN	dobj
,	,	punct
for	IN	prep
at	IN	prep
that	DT	det
time	NN	pobj
the	DT	det
FDA	NNP	nsubj
have	VBD	aux
determine	VBN	advcl
that	IN	mark
"	``	punct
a	DT	det
single	JJ	amod
oral	JJ	amod
dose	NN	nsubj
of	IN	prep
100	CD	nummod
mg	NN	pobj
be	VBZ	ccomp
the	DT	det
maximum	JJ	amod
tolerable	JJ	amod
dose	NN	attr
of	IN	prep
ibandronate	NN	pobj
"	''	punct
.	.	punct

J.A.	NNP	ROOT
8558	CD	nummod
.	.	punct

yet	CC	cc
-PRON-	PRP$	poss
colleague	NNS	nsubj
rely	VBP	ROOT
on	IN	prep
this	DT	det
reference	NN	pobj
as	IN	prep
render	VBG	pcomp
obvious	JJ	amod
Roche	NNP	poss
's	POS	case
specific	JJ	amod
once	RB	nmod
-	HYPH	punct
a	DT	det
-	HYPH	punct
month	NN	pobj
dosage	NN	dobj
of	IN	prep
150	CD	nummod
mg	NN	pobj
.	.	punct

 	_SP	

2	CD	ROOT
.	.	punct

Lunar	NNP	compound
News	NNP	ROOT

 	_SP	

other	JJ	amod
reference	NNS	nsubj
also	RB	advmod
show	VBP	ROOT
that	IN	mark
the	DT	det
field	NN	nsubj
be	VBD	aux
seek	VBG	ccomp
a	DT	det
well	JJR	amod
bisphosphonate	JJ	compound
proto	NN	dobj
col,	NN	nummod
and	CC	cc
that	IN	mark
the	DT	det
problem	NNS	nsubjpass
be	VBD	auxpass
not	RB	neg
solve	VBN	conj
.	.	punct

the	DT	det
Lunar	NNP	compound
News	NNP	nsubj
article,2	NNP	punct
on	IN	prep
which	WDT	pobj
the	DT	det
panel	NN	compound
majority	NN	nsubj
place	VBZ	relcl
heavy	JJ	amod
reliance	NN	dobj
,	,	punct
broadly	RB	advmod
state	VBZ	ROOT
that	IN	mark
some	DT	det
osteoporosis	JJ	compound
agent	NNS	nsubjpass
can	MD	aux
be	VB	auxpass
give	VBN	ccomp
intermittently	RB	advmod
.	.	punct

however	RB	advmod
-PRON-	PRP	nsubj
never	RB	neg
directly	RB	advmod
associate	NNS	nsubj
ibandronate	VBP	ROOT
with	IN	prep
oral	JJ	amod
therapy	NN	pobj
.	.	punct

instead	RB	advmod
,	,	punct
the	DT	det
Lunar	NNP	compound
News	NNP	compound
article	NN	nsubj
state	VBZ	ROOT
the	DT	det
then	RB	advmod
-	HYPH	punct
current	JJ	amod
wisdom	NN	dobj
that	IN	mark
"	``	punct
the	DT	det
project	VBN	amod
mode	NN	nsubj
for	IN	prep
ibandronate	NN	pobj
be	VBZ	ccomp
injection	NN	attr
once	RB	advmod
every	DT	det
three	CD	nummod
month	NNS	npadvmod
"	''	punct
.	.	punct

J.A.	NNP	ROOT
24321	CD	nummod
.	.	punct

contrary	JJ	advmod
to	IN	prep
the	DT	det
panel	NN	compound
majority	NN	pobj
,	,	punct
this	DT	det
article	NN	nsubj
support	VBZ	ROOT
unobviousness	NN	dobj
of	IN	prep
the	DT	det
Roche	NNP	compound
therapy	NN	pobj
,	,	punct
not	RB	neg
obviousness	JJ	dep
.	.	punct

 	_SP	

3	CD	ROOT
.	.	punct

the	DT	det
Chen	NNP	compound
Patent	NNP	ROOT

 	_SP	

the	DT	det
Chen	NNP	compound
patent3	NN	nsubj
be	VBZ	ROOT
similarly	RB	advmod
inapt	VBN	acomp
.	.	punct

Chen	NNP	nsubj
seek	VBD	ROOT
to	TO	aux
minimize	VB	xcomp
the	DT	det
adverse	JJ	amod
effect	NNS	dobj
associate	VBN	acl
with	IN	prep
bisphosphonic	JJ	amod
acid	NNS	pobj
by	IN	prep
combine	VBG	pcomp
the	DT	det
bisphosphonic	JJ	amod
acid	NN	dobj
with	IN	prep
a	DT	det
carrier	NN	pobj
that	WDT	nsubj
act	VBZ	relcl
as	IN	prep
a	DT	det
disperse	VBG	compound
medium	NN	pobj
for	IN	prep
the	DT	det
active	JJ	amod
agent	NN	pobj
.	.	punct

Chen	NNP	nsubj
list	VBZ	ROOT
all	DT	dobj
of	IN	prep
the	DT	det
know	VBN	amod
bisphosphonic	JJ	amod
acid	NNS	pobj
,	,	punct
and	CC	cc
state	VBZ	conj
that	IN	mark
oral	JJ	amod
dosage	NNS	nsubjpass
may	MD	aux
be	VB	auxpass
administer	VBN	ccomp
anywhere	RB	advmod
between	IN	prep
once	RB	advmod
every	DT	det
two	CD	nummod
week	NNS	pobj
and	CC	cc
once	RB	advmod
every	DT	det
twelve	CD	nummod
week	NNS	conj
,	,	punct
with	IN	prep
the	DT	det
optimal	JJ	amod
frequency	NN	pobj
of	IN	prep
once	RB	pobj
every	DT	det
twelve	CD	nummod
week	NNS	pobj
.	.	punct

Chen	NNP	nsubj
do	VBZ	aux
not	RB	neg
provide	VB	ROOT
any	DT	det
example	NN	dobj
use	VBG	advcl
ibandronate	NN	dobj
,	,	punct
and	CC	cc
do	VBZ	aux
not	RB	neg
suggest	VB	conj
a	DT	det
specific	JJ	amod
dosage	NN	dobj
or	CC	cc
dosage	NN	compound
interval	NN	conj
for	IN	prep
any	DT	det
ibandronate	NN	npadvmod
-	HYPH	punct
contain	VBG	amod
product	NN	pobj
.	.	punct

nor	CC	cc
do	VBZ	aux
Chen	NNP	nsubj
state	VB	ROOT
what	WP	dobj
parameter	NNS	nsubj
may	MD	aux
lead	VB	ccomp
to	IN	prep
a	DT	det
successful	JJ	amod
regimen	NN	pobj
.	.	punct

 	_SP	

4	CD	ROOT
.	.	punct

the	DT	det
Geddes	NNP	compound
Patent	NNP	ROOT

 	_SP	

the	DT	det
other	JJ	amod
reference	NNS	nsubj
on	IN	prep
which	WDT	pobj
-PRON-	PRP$	poss
colleague	NNS	nsubj
rely	VBP	relcl
be	VBP	ROOT
no	DT	neg
more	RBR	advmod
helpful	JJ	acomp
to	IN	prep
-PRON-	PRP$	poss
conclusion	NN	pobj
.	.	punct

the	DT	det
Geddes	NNP	compound
patent4	NN	nsubjpass
be	VBZ	auxpass
direct	VBN	ROOT
to	IN	prep
a	DT	det
combination	NN	compound
therapy	NN	pobj
of	IN	prep
a	DT	det
bisphosphonate	NN	compound
compound	NN	pobj
and	CC	cc
a	DT	det
hormone	NN	conj
,	,	punct
and	CC	cc
state	VBZ	conj
that	IN	mark
the	DT	det
bisphosphonate	NN	nsubjpass
may	MD	aux
be	VB	auxpass
dose	VBN	ccomp
from	IN	prep
every	DT	det
day	NN	pobj
to	IN	prep
once	RB	pcomp
a	DT	det
month	NN	npadvmod
.	.	punct

gedde	NNS	nsubj
do	VBZ	aux
not	RB	neg
mention	VB	ROOT
ibandronate	NN	xcomp
or	CC	cc
the	DT	det
dosage	NN	conj
or	CC	cc
suggest	VB	conj
that	IN	mark
-PRON-	PRP	nsubj
may	MD	aux
be	VB	ccomp
effective	JJ	acomp
at	IN	prep
150	CD	nummod
mg	NN	pobj
once	RB	advmod
a	DT	det
month	NN	npadvmod
.	.	punct

 	_SP	

5	CD	ROOT
.	.	punct

the	DT	det
Schofield	NNP	compound
Patent	NNP	compound
Application	NNP	nsubj

 	_SP	
the	DT	det
Schofield	NNP	compound
application,5	:	nsubj
on	IN	prep
which	WDT	pobj
the	DT	det
court	NN	nsubj
also	RB	advmod
rely	VBZ	relcl
,	,	punct
describe	VBZ	ROOT
a	DT	det
treatment	NN	compound
regiman	NNS	dobj
feature	VBG	acl
a	DT	det
front	JJ	amod
-	HYPH	punct
end	NN	nmod
"	''	punct
loading	NN	compound
period	NN	dobj
"	''	punct
of	IN	prep
7	CD	quantmod
to	TO	quantmod
180	CD	nummod
day	NNS	pobj
,	,	punct
follow	VBN	acl
by	IN	agent
a	DT	det
maintenance	NN	compound
dose	NN	pobj
.	.	punct

the	DT	det
loading	NN	compound
dose	NN	nsubjpass
of	IN	prep
bisphosphonate	NN	pobj
may	MD	aux
be	VB	auxpass
give	VBN	ROOT
daily	RB	advmod
or	CC	cc
every	DT	det
other	JJ	amod
day	NN	conj
,	,	punct
while	IN	mark
the	DT	det
maintenance	NN	compound
dose	NN	nsubjpass
may	MD	aux
be	VB	auxpass
give	VBN	advcl
anywhere	RB	advmod
from	IN	prep
daily	RB	pobj
to	IN	prep
monthly	JJ	pobj
.	.	punct

schofield	VB	nsubj
further	JJ	amod
state	NNS	ROOT
that	IN	mark
the	DT	det
loading	NN	compound
dose	NN	nsubj
be	VBZ	ccomp
about	RB	quantmod
two	CD	quantmod
to	TO	quantmod
twenty	CD	npadvmod
time	NNS	quantmod
great	JJR	acomp
than	IN	prep
the	DT	det
maintenance	NN	compound
dose	NN	pobj
.	.	punct

schofield	NN	amod
mention	NNS	nsubj
ibandronate	VBP	ROOT
as	IN	prep
a	DT	det
possible	JJ	amod
active	JJ	amod
agent	NN	pobj
appropriate	JJ	amod
for	IN	prep
use	NN	pobj
in	IN	prep
-PRON-	PRP$	poss
method	NNS	pobj
,	,	punct
but	CC	cc
provide	VBZ	conj
no	DT	det
dosage	NNS	dobj
or	CC	cc
specify	VBN	amod
period	NNS	conj
for	IN	prep
ibandronate	NN	pobj
.	.	punct

 	_SP	

6	CD	ROOT
.	.	punct

the	DT	det
Riis	NNP	compound
Article	NNP	nsubj

 	_SP	
several	JJ	amod
reference	NNS	nsubj
address	VBP	ROOT
intermittent	JJ	amod
treatment	NN	dobj
,	,	punct
but	CC	cc
none	NN	nsubj
suggest	VBZ	conj
once	RB	amod
-	HYPH	punct
monthly	JJ	amod
administration	NN	dobj
of	IN	prep
150	CD	nummod
mg	NN	pobj
of	IN	prep
oral	JJ	amod
ibandronate	NN	pobj
.	.	punct

the	DT	det
court	NN	nsubj
rely	VBZ	ROOT
on	IN	prep
the	DT	det
Riis	NNP	compound
article,6	NNP	pobj
which	WDT	nsubj
show	VBZ	ccomp
dose	VBG	amod
patient	NNS	dobj
with	IN	prep
20	CD	nummod
mg	NN	pobj
of	IN	prep
ibandronate	NN	pobj
every	DT	det
other	JJ	amod
day	NN	npadvmod
for	IN	prep
twenty	CD	compound
-	HYPH	punct
four	CD	nummod
day	NNS	pobj
,	,	punct
follow	VBN	advcl
by	IN	agent
a	DT	det
9-week	CD	compound
period	NN	pobj
of	IN	prep
no	DT	det
treatment	NN	pobj
,	,	punct
then	RB	advmod
return	VBG	advcl
to	IN	prep
20	CD	nummod
mg	NN	pobj
every	DT	det
other	JJ	amod
day	NN	npadvmod
for	IN	prep
twenty	CD	compound
-	HYPH	punct
four	CD	nummod
day	NNS	pobj
,	,	punct
and	CC	cc
a	DT	det
9-week	CD	nummod
period	NN	conj
of	IN	prep
no	DT	det
treatment	NN	pobj
,	,	punct
etc	FW	conj
.	.	punct

the	DT	det
court	NN	nsubj
characterize	VBZ	ROOT
this	DT	dobj
as	IN	prep
definitive	JJ	amod
proof	NN	pobj
of	IN	prep
the	DT	det
"	``	punct
total	JJ	amod
dose	VBG	compound
concept	NN	pobj
"	''	punct
.	.	punct

however	RB	advmod
,	,	punct
Riis	NNP	nsubj
make	VBZ	ROOT
no	DT	det
suggestion	NN	dobj
that	IN	mark
the	DT	det
once	RB	amod
-	HYPH	punct
a	DT	det
-	HYPH	punct
month	NN	dobj
dose	VBG	nsubj
at	IN	prep
the	DT	det
high	JJ	amod
dosage	NN	pobj
use	VBN	acl
by	IN	agent
Roche	NNP	pobj
could	MD	aux
replace	VB	acl
Riis	NNP	poss
'	POS	case
elaborate	JJ	amod
procedure	NN	dobj
.	.	punct

 	_SP	

Riis	NNP	nsubj
illustrate	VBZ	ROOT
the	DT	det
general	JJ	amod
belief	NN	dobj
that	IN	mark
some	DT	det
sort	NN	nsubjpass
of	IN	prep
complex	JJ	amod
dosing	NN	pobj
be	VBZ	auxpass
need	VBN	acl
if	IN	mark
daily	JJ	amod
dos	NNS	nsubjpass
be	VBP	auxpass
supplant	VBN	advcl
.	.	punct

the	DT	det
simplicity	NN	ROOT
of	IN	prep
the	DT	det
Boniva	NNPS	pobj
(r)	SYM	intj

regimen	NN	nsubj
be	VBZ	ROOT
nowhere	RB	advmod
to	TO	aux
be	VB	auxpass
find	VBN	xcomp
,	,	punct
although	IN	mark
the	DT	det
need	NN	nsubjpass
for	IN	prep
a	DT	det
well	JJR	amod
regimen	NN	pobj
be	VBD	auxpass
well	RB	advmod
recognize	VBN	advcl
.	.	punct

see	VB	ROOT
Graham	NNP	dobj
,	,	punct
383	CD	nummod
U.S.	NNP	appos
at	IN	prep
18	CD	pobj
,	,	punct

86	CD	nummod
S.Ct	NNP	ROOT
.	.	punct

684	CD	dep
(	-LRB-	punct
objective	JJ	amod
evidence	NN	nsubj
of	IN	prep
nonobviousness	NN	pobj
include	VBZ	ROOT
long	RB	advmod
-	HYPH	punct
feel	VBN	compound
need	NN	dobj
and	CC	cc
failure	NN	conj
of	IN	prep
other	NNS	pobj
)	-RRB-	punct
.	.	punct

rii	NNS	nsubj
contain	VBZ	ROOT
no	DT	det
suggestion	NN	dobj
that	IN	mark
a	DT	det
once	RB	advmod
-	HYPH	punct
monthly	JJ	amod
dosage	NN	nsubj
of	IN	prep
150	CD	nummod
mg	NN	pobj
would	MD	aux
be	VB	acl
both	CC	preconj
safe	JJ	acomp
and	CC	cc
effective	JJ	conj
-	:	punct
this	DT	nsubjpass
become	VBD	auxpass
know	VBN	acl
only	RB	advmod
after	IN	mark
Roche	NNP	nsubj
discover	VBD	advcl
-PRON-	PRP	dobj
.	.	punct

 	_SP	

7	CD	ROOT
.	.	punct

the	DT	det
Recker	NNP	compound
Study	NNP	ROOT

 	_SP	

By	IN	prep
comparison	NN	pobj
,	,	punct
the	DT	det
Recker	NNP	compound
article,7	NNP	nsubj
which	WDT	nsubj
set	VBZ	relcl
forth	RB	advmod
in	IN	prep
-PRON-	PRP$	poss
introduction	NN	pobj
the	DT	det
state	NN	dobj
of	IN	prep
the	DT	det
art	NN	pobj
in	IN	prep
2004	CD	pobj
,	,	punct
state	VBZ	ROOT
that	IN	mark
"	``	punct
oral	JJ	amod
bisphosphonate	NNS	nsubjpass
must	MD	aux
be	VB	auxpass
administer	VBN	ccomp
frequently	RB	advmod
(	-LRB-	punct
e.g.	JJ	advmod
,	,	punct
daily	JJ	advmod
or	CC	cc
weekly	JJ	conj
)	-RRB-	punct
"	''	punct
and	CC	cc
in	IN	conj
accordance	NN	pobj
with	IN	prep
"	``	punct
stringent	JJ	amod
dosing	JJ	amod
recommendation	NNS	pobj
"	''	punct
.	.	punct

 	_SP	

only	RB	advmod
this	DT	det
court	NN	nsubj
read	VBZ	ROOT
the	DT	det
prior	JJ	amod
art	NN	dobj
to	TO	aux
suggest	VB	relcl
and	CC	cc
render	VB	conj
obvious	JJ	dobj
that	IN	dobj
which	WDT	nsubj
elude	VBD	relcl
the	DT	det
art	NN	dobj
at	IN	prep
the	DT	det
time	NN	pobj
.	.	punct

 	_SP	

8	CD	ROOT
.	.	punct

the	DT	det
Ravn	NNP	compound
Study	NNP	ROOT

 	_SP	

the	DT	det
court	NN	nsubj
attempt	VBZ	ROOT
to	TO	aux
overcome	VB	xcomp
the	DT	det
shortcoming	NNS	dobj
of	IN	prep
the	DT	det
prior	JJ	amod
art	NN	pobj
by	IN	prep
apply	VBG	pcomp
the	DT	det
total	JJ	amod
dose	NN	compound
concept	NN	dobj
of	IN	prep
Riis	NNP	pobj
to	IN	prep
the	DT	det
dosage	NN	pobj
range	VBZ	pobj
in	IN	prep
the	DT	det
Ravn8	NNP	compound
reference	NN	pobj
.	.	punct

Ravn	NNP	nsubj
test	VBD	ROOT
daily	JJ	amod
treatment	NN	dobj
use	VBG	acl
a	DT	det
range	NN	dobj
of	IN	prep
dosage	NNS	pobj
and	CC	cc
conclude	VBD	conj
that	IN	mark
2.5	CD	nummod
mg	NN	nsubj
per	IN	prep
day	NN	pobj
be	VBZ	ccomp
the	DT	det
most	RBS	advmod
effective	JJ	amod
dose	NN	attr
.	.	punct

yet	CC	advmod
the	DT	det
court	NN	nsubj
select	VBZ	ROOT
Ravn	NNP	poss
's	POS	case
5.0	CD	nummod
mg	NN	compound
dose	NN	dobj
,	,	punct
despite	IN	prep
-PRON-	PRP$	poss
increased	JJ	amod
toxicity	NN	pobj
and	CC	cc
Ravn	NNP	poss
's	POS	case
preference	NN	conj
for	IN	prep
the	DT	det
low	JJR	amod
dose	NN	pobj
,	,	punct
to	TO	aux
scale	VB	advcl
up	RP	prt
to	IN	prep
Roche	NNP	poss
's	POS	case
150	CD	nummod
mg	NN	compound
dose	NN	pobj
.	.	punct

ravn	NN	nsubj
do	VBZ	aux
not	RB	neg
suggest	VB	ROOT
a	DT	det
once	RB	advmod
-	HYPH	punct
monthly	JJ	amod
dose	NN	dobj
of	IN	prep
150	CD	nummod
mg	NN	pobj
.	.	punct

 	_SP	

-PRON-	PRP	nsubj
be	VBZ	ROOT
also	RB	advmod
noteworthy	JJ	acomp
that	IN	mark
the	DT	det
Riis	NNP	compound
publication	NN	nsubj
,	,	punct
which	WDT	nsubj
be	VBZ	relcl
later	RB	advmod
in	IN	prep
time	NN	pobj
than	IN	prep
Ravn	NNP	pobj
,	,	punct
select	VBD	ccomp
the	DT	det
2.5	CD	nummod
mg	NN	compound
dosage	NN	dobj
,	,	punct
not	RB	neg
the	DT	det
5.0	CD	nummod
mg	NN	compound
dosage	NN	appos
,	,	punct
as	IN	prep
a	DT	det
framework	NN	pobj
for	IN	prep
intermittent	NN	amod
dosing	NN	pobj
.	.	punct

 	_SP	

9	CD	ROOT
.	.	punct

the	DT	det
Daifotis	NNP	compound
Patent	NNP	ROOT

 	_SP	

the	DT	det
panel	NN	compound
majority	NN	nsubj
also	RB	advmod
cite	VBZ	ROOT
a	DT	det
patent	NN	dobj
issue	VBN	acl
to	IN	prep
Roche	NNP	poss
's	POS	case
expert	NN	pobj
Dr.	NNP	compound
Daifotis9	NNP	appos
as	IN	prep
evidence	NN	pobj
of	IN	prep
obviousness	NN	pobj
of	IN	prep
monthly	JJ	amod
oral	JJ	amod
dosing	NN	pobj
.	.	punct

Dr.	NNP	compound
Daifotis	NNP	nsubj
describe	VBD	ROOT
dosing	JJ	compound
schedule	NNS	dobj
range	VBG	acl
from	IN	prep
twice	PDT	predet
a	DT	det
week	NN	pobj
to	TO	prep
twice	PDT	predet
a	DT	det
month	NN	pobj
,	,	punct
and	CC	cc
recommend	VBD	conj
once	RB	nmod
-	HYPH	punct
a	DT	det
-	HYPH	punct
week	NN	appos
dosing	NN	dobj
of	IN	prep
7	CD	nummod
mg	NN	pobj
to	IN	prep
100	CD	nummod
mg	NN	pobj
,	,	punct
with	IN	prep
a	DT	det
preferred	JJ	amod
range	NN	pobj
of	IN	prep
35	CD	nummod
mg	NN	pobj
to	IN	prep
50	CD	nummod
mg	NN	pobj
per	IN	prep
week	NN	pobj
.	.	punct

Daifotis	NNP	nsubj
do	VBZ	aux
not	RB	neg
show	VB	ROOT
or	CC	cc
suggest	VB	conj
any	DT	det
monthly	JJ	amod
dosage	NN	dobj
,	,	punct
or	CC	cc
that	IN	mark
monthly	JJ	amod
dosing	NN	nsubj
may	MD	aux
be	VB	conj
effective	JJ	acomp
.	.	punct

nonetheless	RB	advmod
the	DT	det
panel	NN	compound
majority	NN	nsubj
select	VBZ	ROOT
the	DT	det
Daifotis	NNP	nmod
35	CD	nummod
mg	NN	dobj
per	IN	prep
week	NN	compound
dosage	NN	pobj
,	,	punct
calculate	VBZ	conj
that	IN	mark
35	CD	nummod
mg	NN	quantmod
time	NNS	nsubj
4	CD	nummod
week	NNS	appos
be	VBZ	ccomp
about	RB	advmod
150	CD	nummod
mg	NN	attr
per	IN	prep
month	NN	pobj
,	,	punct
and	CC	cc
combine	VBZ	conj
this	DT	det
calculation	NN	dobj
with	IN	prep
Riis	NNP	pobj
and	CC	cc
Ravn	NNP	conj
to	TO	aux
find	VB	advcl
obvious	JJ	amod
the	DT	det
Roche	NNP	compound
combination	NN	dobj
of	IN	prep
dosage	NN	pobj
and	CC	cc
schedule	NN	conj
.	.	punct

 	_SP	

B.	NNP	ROOT

the	DT	det
Bioavailability	NNP	compound
Explanation	NNP	nsubj

 	_SP	
-PRON-	PRP$	poss
colleague	NNS	nsubj
agree	VBP	ROOT
that	IN	mark
the	DT	det
result	NNS	nsubjpass
achieve	VBN	acl
with	IN	prep
the	DT	det
Boniva	NNP	nmod
(r)	SYM	compound
product	NN	pobj
be	VBD	auxpass
not	RB	neg
suggest	VBN	ccomp
or	CC	cc
predict	VBN	conj
.	.	punct

In	IN	prep
-PRON-	PRP$	poss
expert	NN	compound
report	NN	pobj
Dr.	NNP	compound
Daifotis	NNP	nsubj
discuss	VBD	ccomp
the	DT	det
scientific	JJ	amod
basis	NN	dobj
that	WDT	nsubjpass
have	VBD	aux
later	RB	advmod
be	VBN	auxpass
find	VBN	relcl
to	TO	aux
explain	VB	xcomp
the	DT	det
successful	JJ	amod
treatment	NN	dobj
obtain	VBN	acl
with	IN	prep
this	DT	det
proto	NN	pobj
col.	NN	npadvmod
Dr.	NNP	compound
Daifotis	NNP	nsubj
present	VBD	ROOT
a	DT	det
publish	VBN	amod
scientific	JJ	amod
article	NN	dobj
by	IN	prep
Reginster10	NNP	nmod
et	NNP	compound
al	NNP	pobj
.	.	punct
show	VBG	advcl
the	DT	det
disproportionate	JJ	amod
uptake	NN	dobj
of	IN	prep
ibandronate	NN	pobj
into	IN	prep
the	DT	det
blood	NN	compound
stream	NN	pobj
,	,	punct
an	DT	det
unpredicted	JJ	amod
and	CC	cc
unusual	JJ	conj
result	NN	appos
.	.	punct

Dr.	NNP	compound
Daifotis	NNP	nsubj
testify	VBD	ROOT
that	IN	mark
this	DT	nsubj
explain	VBZ	ccomp
the	DT	det
unexpected	JJ	amod
efficacy	NN	dobj
of	IN	prep
Roche	NNP	poss
's	POS	case
150	CD	nummod
mg	NN	compound
dose	NN	pobj
.	.	punct

the	DT	det
record	NN	nsubj
contain	VBZ	ROOT
the	DT	det
follow	VBG	amod
graphical	JJ	amod
portrayal	NN	dobj
,	,	punct
where	WRB	advmod
the	DT	det
mean	JJ	amod
area	NN	nsubj
under	IN	prep
the	DT	det
curve	NN	pobj
(	-LRB-	punct
AUC	NNP	appos
)	-RRB-	punct
indicate	VBZ	relcl
the	DT	det
average	JJ	amod
concentration	NN	dobj
of	IN	prep
ibandronate	NN	pobj
in	IN	prep
the	DT	det
blood	NN	pobj
:	:	punct

 	_SP	

Dr.	NNP	compound
Daifotis	NNP	nsubj
explain	VBD	ROOT
that	IN	mark
"	``	punct
this	DT	nsubj
be	VBD	ccomp
a	DT	det
surprising	JJ	amod
finding	NN	attr
concern	VBG	acl
the	DT	det
disproportionate	JJ	amod
amount	NN	dobj
of	IN	prep
ibandronate	NN	pobj
that	WDT	nsubj
become	VBZ	relcl
available	JJ	acomp
from	IN	prep
oral	JJ	amod
administration	NN	pobj
of	IN	prep
amount	NNS	pobj
above	IN	prep
about	RB	advmod
50	CD	nummod
mg	NN	pobj
,	,	punct
and	CC	cc
-PRON-	PRP	nsubj
be	VBD	conj
unknown	JJ	acomp
as	IN	prep
of	IN	prep
May	NNP	pobj
2002	CD	nummod
"	''	punct
.	.	punct

J.A.	NNP	ROOT
20726	CD	nummod
-	SYM	punct
27	CD	prep
?	.	punct

108	CD	ROOT
.	.	punct

Dr.	NNP	compound
Daifotis	NNP	nsubj
explain	VBD	ROOT
that	IN	mark
"	``	punct
the	DT	det
benefit	NN	nsubj
of	IN	prep
this	DT	det
surprising	JJ	amod
result	NN	pobj
be	VBD	ccomp
that	IN	mark
a	DT	det
patient	NN	nsubj
could	MD	aux
receive	VB	ccomp
high	JJR	advmod
than	IN	mark
think	VBN	advcl
possible	JJ	amod
amount	NNS	nsubj
of	IN	prep
active	JJ	amod
drug	NN	pobj
to	TO	aux
be	VB	ccomp
available	JJ	acomp
to	TO	aux
inhibit	VB	xcomp
osteoclast	NNS	dobj
,	,	punct
while	IN	mark
at	IN	advcl
the	DT	det
time	NN	pobj
not	RB	neg
adversely	RB	advmod
affect	VBG	acl
the	DT	det
safety	NN	compound
profile	NN	dobj
of	IN	prep
a	DT	det
150	CD	nummod
mg	NN	compound
dose	NN	pobj
of	IN	prep
ibandronate	NN	pobj
"	''	punct
.	.	punct

J.A.	NNP	ROOT
20732	CD	nummod
?	.	punct

115	CD	ROOT
.	.	punct

 	_SP	

Dr.	NNP	compound
Daifotis	NNP	nsubj
also	RB	advmod
cite	VBD	ROOT
clinical	JJ	amod
trial	NN	compound
datum	NNS	dobj
show	VBG	acl
that	IN	mark
a	DT	det
150	CD	nummod
mg	NN	nmod
monthly	JJ	amod
dose	NN	nsubj
of	IN	prep
ibandronate	NN	pobj
be	VBZ	ccomp
superior	JJ	acomp
at	IN	prep
increase	VBG	amod
bone	NN	compound
density	NN	pobj
in	IN	prep
the	DT	det
lumbar	JJ	compound
spine	NN	pobj
of	IN	prep
postmenopausal	NN	amod
woman	NNS	pobj
,	,	punct
as	IN	mark
compare	VBN	advcl
to	IN	prep
100	CD	nummod
mg	NN	pobj
give	VBN	acl
once	RB	advmod
a	DT	det
month	NN	npadvmod
,	,	punct
50	CD	nummod
mg	NN	nsubj
give	VBN	prep
on	IN	prep
two	CD	nummod
consecutive	JJ	amod
day	NNS	pobj
in	IN	prep
a	DT	det
single	JJ	amod
month	NN	pobj
(	-LRB-	punct
50/50	CD	appos
)	-RRB-	punct
and	CC	cc
a	DT	det
2.5	CD	nummod
mg	NN	nmod
daily	JJ	amod
dose	NN	conj
.	.	punct

 	_SP	

the	DT	det
record	NN	nsubj
contain	VBZ	ROOT
other	JJ	amod
scientific	JJ	amod
article	NNS	dobj
,	,	punct
e.g.	RB	advmod
,	,	punct
Paul	NNP	compound
D.	NNP	compound
Miller	NNP	nmod
et	NNP	compound
al	NNP	subtok
.	.	punct
,	,	punct
Monthly	NNP	compound
Oral	NNP	compound
Ibandronate	NNP	compound
Therapy	NNP	npadvmod
in	IN	prep
Postmenopausal	NNP	compound
Osteoporosis	NNP	pobj
:	:	punct
1-year	CD	appos
from	IN	prep
the	DT	det
Mobile	NNP	compound
Study	NNP	pobj
,	,	punct
20	CD	nummod
J.	NNP	compound
BONE	NNP	compound
MINER	NNP	appos
.	.	punct

RES	NNP	ROOT
..	NFP	punct

1315	CD	ROOT
-	SYM	punct
22	CD	prep
(	-LRB-	punct
2005	CD	appos
)	-RRB-	punct
.	.	punct

Nothing	NN	nsubj
in	IN	prep
the	DT	det
prior	JJ	amod
art	NN	pobj
render	VBZ	ROOT
the	DT	det
result	NN	dobj
expect	VBD	acl
,	,	punct
predict	VBN	conj
,	,	punct
or	CC	cc
obvious	JJ	conj
.	.	punct

 	_SP	

C.	NNP	compound
Expert	NNP	compound
Testimony	NNP	nsubj

 	_SP	
also	RB	advmod
of	IN	prep
record	NN	pobj
be	VBD	ROOT
the	DT	det
report	NNS	attr
of	IN	prep
Roche	NNP	poss
's	POS	case
expert	NNS	pobj
Dr.	NNP	compound
Bilezikian	NNP	appos
and	CC	cc
Dr.	NNP	compound
Harris	NNP	conj
.	.	punct

Roche	NNP	nsubj
explain	VBD	ROOT
that	IN	mark
each	DT	det
opine	NNS	nsubj
that	WDT	nsubj
,	,	punct
at	IN	prep
the	DT	det
time	NN	pobj
of	IN	prep
the	DT	det
invention	NNS	pobj
,	,	punct
a	DT	det
person	NN	nsubj
skilled	JJ	amod
in	IN	prep
the	DT	det
art	NN	pobj
would	MD	aux
not	RB	neg
have	VB	aux
have	VBN	ccomp
any	DT	det
reasonable	JJ	amod
expectation	NN	dobj
of	IN	prep
succeed	VBG	pcomp
with	IN	prep
a	DT	det
safe	JJ	amod
,	,	punct
effective	JJ	conj
,	,	punct
and	CC	cc
well	RB	advmod
-	HYPH	punct
tolerate	VBN	conj
once	RB	advmod
-	HYPH	punct
monthly	JJ	amod
oral	JJ	amod
dosage	NN	pobj
of	IN	prep
ibandronate	NN	pobj
in	IN	prep
an	DT	det
amount	NN	pobj
as	RB	advmod
large	JJ	amod
as	IN	prep
150	CD	nummod
mg	NN	pobj
.	.	punct

 	_SP	

the	DT	det
trier	NN	nsubj
of	IN	prep
fact	NN	pobj
be	VBZ	ROOT
"	``	punct
requir[ed	JJ	attr
to	TO	aux
]	-RRB-	punct
consider	VB	xcomp
all	DT	det
evidence	NN	dobj
relate	VBG	acl
to	IN	prep
obviousness	JJ	pobj
before	IN	prep
find	VBG	pcomp
a	DT	det
patent	NN	compound
invalid	JJ	dobj
on	IN	prep
those	DT	det
ground	NNS	pobj
"	''	punct
.	.	punct

In	IN	ROOT
re	NN	pobj
Cyclobenzaprine	NNP	compound
Hydrochloride	NNP	compound
Extended	NNP	compound
-	HYPH	punct
Release	NNP	compound
Capsule	NNP	compound
Patent	NNP	compound
Litig	NNP	pobj
.	.	pobj
,	,	punct
676	CD	nummod
f.3d	CD	appos
1063	CD	nummod
,	,	punct
1075	CD	npadvmod
(	-LRB-	punct
Fed	NNP	nmod
.	.	punct
Cir.2012	NNS	appos
)	-RRB-	punct
.	.	punct

-PRON-	PRP	nsubj
be	VBZ	ROOT
noteworthy	JJ	acomp
that	IN	mark
although	IN	mark
the	DT	det
generic	JJ	amod
producer	NNS	nsubj
who	WP	nsubj
be	VBP	relcl
defendant	NNS	compound
herein	NN	attr
also	RB	advmod
present	VBD	advcl
expert	NN	compound
report	NNS	dobj
,	,	punct
no	DT	det
expert	NN	nsubj
provide	VBD	ccomp
anything	NN	dobj
other	JJ	amod
than	IN	prep
a	DT	det
personal	JJ	amod
opinion	NN	pobj
that	IN	mark
the	DT	det
Roche	NNP	compound
discovery	NN	nsubj
be	VBD	acl
obvious	JJ	acomp
.	.	punct

 	_SP	

the	DT	det
evidence	NN	ROOT
of	IN	prep
long	RB	advmod
-	HYPH	punct
feel	VBN	compound
need	NN	pobj
,	,	punct
failure	NN	appos
of	IN	prep
other	NNS	pobj
,	,	punct
and	CC	cc
commercial	JJ	amod
success	NN	nsubjpass
be	VBD	auxpass
unrebutted	JJ	conj
,	,	punct
and	CC	cc
no	DT	det
adverse	JJ	amod
expert	NN	nsubj
provide	VBD	conj
any	DT	det
evidence	NN	dobj
from	IN	prep
which	WDT	pobj
the	DT	det
success	NN	nsubjpass
of	IN	prep
the	DT	det
Boniva	NNP	nmod
(r)	SYM	compound
product	NN	pobj
could	MD	aux
be	VB	auxpass
confidently	RB	advmod
predict	VBN	relcl
.	.	punct

-PRON-	PRP$	poss
only	JJ	amod
argument	NN	nsubj
be	VBD	ROOT
that	IN	mark
-PRON-	PRP	nsubj
would	MD	aux
have	VB	aux
be	VBN	ccomp
"	``	punct
obvious	JJ	acomp
to	TO	aux
try	VB	xcomp
"	``	punct
the	DT	det
Roche	NNP	compound
method	NN	dobj
.	.	punct

of	RB	advmod
course	RB	advmod
,	,	punct
-PRON-	PRP	nsubj
be	VBZ	ROOT
possible	JJ	acomp
to	TO	aux
speculate	VB	xcomp
about	IN	prep
all	DT	det
sort	NNS	pobj
of	IN	prep
treatment	NN	compound
schedule	NNS	pobj
,	,	punct
as	IN	mark
in	IN	prep
the	DT	det
Krause	NNP	pobj
newsletter,11	NFP	pobj
but	CC	cc
speculation	NN	nsubj
without	IN	prep
specificity	NN	pobj
and	CC	cc
a	DT	det
plan	NN	conj
for	IN	prep
achieve	VBG	pcomp
a	DT	det
reasonable	JJ	amod
likelihood	NN	dobj
of	IN	prep
success	NN	pobj
do	VBZ	aux
not	RB	neg
provide	VB	conj
clear	JJ	advmod
and	CC	cc
convincing	JJ	conj
evidence	NN	dobj
of	IN	prep
obviousness	NN	pobj
on	IN	prep
the	DT	det
ground	NN	pobj
of	IN	prep
"	``	punct
obvious	JJ	pobj
to	TO	aux
try	VB	relcl
"	''	punct
.	.	punct

 	_SP	

D.	NNP	compound
obvious	JJ	ROOT
to	TO	aux
try	VB	relcl

 	_SP	

For	IN	mark
an	DT	det
invention	NN	nsubj
to	TO	aux
be	VB	advcl
obvious	JJ	acomp
to	TO	aux
try	VB	xcomp
,	,	punct
there	EX	expl
must	MD	aux
be	VB	ROOT
a	DT	det
finite	JJ	amod
number	NN	attr
of	IN	prep
know	VBN	amod
choice	NNS	pobj
in	IN	prep
the	DT	det
prior	JJ	amod
art	NN	pobj
,	,	punct
and	CC	cc
a	DT	det
reasonable	JJ	amod
expectation	NN	conj
of	IN	prep
success	NN	pobj
for	IN	prep
the	DT	det
choice	NN	pobj
that	WDT	nsubjpass
be	VBZ	auxpass
try	VBN	relcl
.	.	punct

KSR	NNP	ROOT
,	,	punct
550	CD	nummod
U.S.	NNP	appos
at	IN	prep
421	CD	pobj
,	,	punct
127	CD	nummod
S.Ct	NNP	subtok
.	.	punct
1727	CD	appos
.	.	punct

obvious	JJ	nsubjpass
to	TO	aux
try	VB	advcl
can	MD	aux
not	RB	neg
be	VB	auxpass
find	VBN	ROOT
when	WRB	advmod
the	DT	det
prior	JJ	amod
art	NN	nsubj
give	VBZ	advcl
no	DT	det
hint	NN	dobj
that	IN	mark
a	DT	det
specific	JJ	amod
trial	NN	nsubj
may	MD	aux
achieve	VB	acl
the	DT	det
desire	VBN	amod
result	NN	dobj
.	.	punct

In	IN	ROOT
re	NN	pobj
Kubin	NNP	pobj
,	,	punct
561	CD	nummod
f.3d	CD	pobj
1351	CD	nummod
,	,	punct
1359	CD	appos
(	-LRB-	punct
Fed	NNP	nmod
.	.	punct
Cir.2009	LS	appos
)	-RRB-	punct
(	-LRB-	punct
quote	VBG	acl
in	RP	prep
re	NN	compound
O'Farrell	NNP	pobj
,	,	punct
853	CD	nummod
f.2d	CD	nummod
894	CD	appos
,	,	punct
903	CD	nummod
(	-LRB-	punct
Fed	NNP	nmod
.	.	punct
cir.1988	CD	dobj
)	-RRB-	punct
)	-RRB-	punct
.	.	punct

Dr.	NNP	compound
Daifotis	NNP	nsubj
testify	VBD	ccomp
,	,	punct
"	``	punct
monthly	JJ	amod
oral	JJ	amod
dosing	NN	nsubjpass
of	IN	prep
alendronate	NN	pobj
be	VBD	auxpass
not	RB	neg
see	VBN	ccomp
as	IN	prep
a	DT	det
feasible	JJ	amod
or	CC	cc
desirable	JJ	conj
endeavor	NN	pobj
for	IN	prep
investigation	NN	pobj
;	:	punct
if	IN	mark
-PRON-	PRP	nsubj
have	VBD	aux
be	VBN	advcl
,	,	punct
-PRON-	PRP	nsubj
would	MD	aux
have	VB	aux
explore	VBN	ROOT
-PRON-	PRP	dobj
"	''	punct
.	.	punct

J.A.	NNP	ROOT
20717	CD	nummod
.	.	punct

 	_SP	

the	DT	det
law	NN	nsubj
of	IN	prep
"	``	punct
obvious	JJ	pcomp
to	TO	aux
try	VB	relcl
"	''	punct
require	VBZ	ROOT
that	IN	mark
there	EX	expl
be	VB	ccomp
a	DT	det
limited	JJ	amod
number	NN	attr
of	IN	prep
define	VBN	amod
alternative	NNS	pobj
and	CC	cc
a	DT	det
suggestion	NN	conj
that	IN	mark
the	DT	det
desire	VBN	amod
result	NN	nsubj
be	VBZ	acl
likely	JJ	acomp
to	TO	aux
be	VB	auxpass
achieve	VBN	xcomp
through	IN	prep
the	DT	det
propose	VBN	amod
trial	NN	pobj
.	.	punct

the	DT	det
Court	NNP	nsubj
state	VBD	ROOT
:	:	punct

 	_SP	

when	WRB	advmod
there	EX	expl
be	VBZ	advcl
a	DT	det
design	NN	compound
need	NN	attr
or	CC	cc
market	NN	compound
pressure	NN	conj
to	TO	aux
solve	VB	acl
a	DT	det
problem	NN	dobj
and	CC	cc
there	EX	expl
be	VBP	conj
a	DT	det
finite	JJ	amod
number	NN	attr
of	IN	prep
identify	VBN	amod
,	,	punct
predictable	JJ	amod
solution	NNS	pobj
,	,	punct
a	DT	det
person	NN	nsubj
of	IN	prep
ordinary	JJ	amod
skill	NN	pobj
have	VBZ	ROOT
good	JJ	amod
reason	NN	dobj
to	TO	aux
pursue	VB	relcl
the	DT	det
know	VBN	amod
option	NNS	dobj
within	IN	prep
-PRON-	PRP$	poss
or	CC	cc
-PRON-	PRP$	poss
technical	JJ	amod
grasp	NN	pobj
.	.	punct

If	IN	mark
this	DT	nsubj
lead	VBZ	advcl
to	IN	prep
the	DT	det
anticipate	VBN	amod
success	NN	pobj
,	,	punct
-PRON-	PRP	nsubj
be	VBZ	ROOT
likely	RB	acomp
the	DT	det
product	NN	attr
not	RB	neg
of	IN	prep
innovation	NN	pobj
but	CC	cc
of	IN	conj
ordinary	JJ	amod
skill	NN	pobj
and	CC	cc
common	JJ	amod
sense	NN	conj
.	.	punct

 	_SP	

KSR	NNP	ROOT
,	,	punct
550	CD	nummod
U.S.	NNP	appos
at	IN	prep
421	CD	pobj
,	,	punct
127	CD	nummod
S.Ct	NNP	subtok
.	.	punct
1727	CD	appos
.	.	punct

here	RB	advmod
,	,	punct
however	RB	advmod
,	,	punct
even	RB	advmod
-PRON-	PRP$	poss
colleague	NNS	nsubj
agree	VBP	ROOT
that	IN	mark
the	DT	det
result	NN	nsubj
be	VBD	ccomp
unpredicted	JJ	acomp
,	,	punct
and	CC	cc
that	IN	mark
there	EX	expl
be	VBD	conj
no	DT	det
suggestion	NN	attr
in	IN	prep
the	DT	det
prior	JJ	amod
art	NN	pobj
,	,	punct
or	CC	cc
in	IN	conj
common	JJ	amod
sense	NN	pobj
,	,	punct
that	IN	mark
this	DT	det
procedure	NN	nsubj
may	MD	aux
produce	VB	advcl
the	DT	det
seek	VBN	amod
-	HYPH	punct
after	IN	prt
result	NN	dobj
.	.	punct

nonetheless	RB	advmod
,	,	punct
-PRON-	PRP$	poss
colleague	NNS	nsubj
invalidate	VBP	ROOT
the	DT	det
successful	JJ	amod
treatment	NN	dobj
as	IN	prep
"	``	punct
obvious	JJ	amod
to	TO	aux
try	VB	xcomp
"	''	punct
.	.	punct

 	_SP	

the	DT	det
extensive	JJ	amod
experimentation	NN	nsubj
with	IN	prep
other	JJ	amod
regimen	NNS	pobj
and	CC	cc
dosage	NNS	conj
demonstrate	VBZ	ROOT
that	IN	mark
this	DT	det
selection	NN	nsubj
be	VBD	ccomp
not	RB	neg
obvious	JJ	acomp
to	TO	aux
try	VB	xcomp
.	.	punct

the	DT	det
failure	NN	nsubj
to	TO	aux
meet	VB	acl
this	DT	det
long	RB	advmod
-	HYPH	punct
feel	VBN	compound
need	NN	dobj
weigh	VBZ	ROOT
heavily	RB	advmod
against	IN	prep
-PRON-	PRP$	poss
colleague	NNS	poss
'	POS	case
find	VBG	pobj
that	IN	mark
the	DT	det
Roche	NNP	compound
proto	NN	nsubj
col,	NN	ccomp
although	IN	mark
not	RB	neg
obvious	JJ	advcl
to	IN	prep
investigator	NNS	pobj
in	IN	prep
the	DT	det
field	NN	pobj
,	,	punct
be	VBZ	conj
obvious	JJ	acomp
to	IN	prep
this	DT	det
court	NN	pobj
.	.	punct

As	IN	mark
state	VBN	advcl
in	IN	prep
In	IN	prep
re	NN	pobj
Soni	NNP	pobj
,	,	punct
54	CD	nummod
f.3d	CD	npadvmod
746	CD	nummod
,	,	punct
750	CD	nummod
(	-LRB-	punct
Fed	NNP	nmod
.	.	punct
Cir.1995	NNS	ccomp
)	-RRB-	punct
,	,	punct
"	''	punct
the	DT	det
basic	JJ	amod
principle	NN	nsubj
behind	IN	prep
this	DT	det
rule	NN	pobj
be	VBZ	ROOT
straightforward	JJ	acomp
-	:	punct
that	IN	dobj
which	WDT	nsubj
would	MD	aux
have	VB	aux
be	VBN	ccomp
surprising	JJ	acomp
to	IN	prep
a	DT	det
person	NN	pobj
of	IN	prep
ordinary	JJ	amod
skill	NN	pobj
in	IN	prep
the	DT	det
particular	JJ	amod
art	NN	pobj
would	MD	aux
not	RB	neg
have	VB	aux
be	VBN	conj
obvious	JJ	acomp
"	''	punct
.	.	punct

As	IN	mark
establish	VBN	advcl
in	IN	prep
KSR	NNP	pobj
,	,	punct
absent	JJ	amod
limited	JJ	amod
alternative	NNS	dobj
and	CC	cc
some	DT	det
direction	NN	conj
toward	IN	prep
the	DT	det
successful	JJ	amod
path	NN	pobj
,	,	punct
"	''	punct
obvious	JJ	csubj
to	TO	aux
try	VB	relcl
"	''	punct
be	VBZ	ROOT
not	RB	neg
applicable	JJ	acomp
.	.	punct

 	_SP	

the	DT	det
prior	JJ	amod
art	NN	nsubj
do	VBZ	aux
not	RB	neg
suggest	VB	ROOT
the	DT	det
Roche	NNP	compound
proto	NN	dobj
col,	NN	appos
or	CC	cc
that	IN	mark
-PRON-	PRP	nsubj
may	MD	aux
have	VB	ccomp
a	DT	det
reasonable	JJ	amod
expectation	NN	dobj
of	IN	prep
success	NN	pobj
.	.	punct

only	RB	advmod
with	IN	prep
knowledge	NN	pobj
of	IN	prep
Roche	NNP	poss
's	POS	case
success	NN	pobj
,	,	punct
can	MD	aux
one	CD	nummod
reconstruct	VB	ROOT
that	IN	mark
which	WDT	nsubjpass
be	VBZ	auxpass
not	RB	neg
suggest	VBN	relcl
in	IN	prep
the	DT	det
prior	JJ	amod
art	NN	pobj
.	.	punct

If	IN	prep
anything	NN	pobj
,	,	punct
the	DT	det
large	JJ	amod
amount	NN	nsubj
of	IN	prep
study	NN	pobj
and	CC	cc
publication	NN	conj
add	VBZ	ROOT
to	IN	prep
the	DT	det
uncertainty	NN	pobj
,	,	punct
for	IN	mark
-PRON-	PRP	nsubj
provide	VBZ	advcl
no	DT	det
direction	NN	dobj
for	IN	prep
potential	JJ	amod
success	NN	pobj
.	.	punct

the	DT	det
court	NN	poss
's	POS	case
holding	NN	nsubj
today	NN	npadvmod
will	MD	aux
simply	RB	advmod
discourage	VB	ROOT
improvement	NNS	dobj
in	IN	prep
crowded	JJ	amod
field	NNS	pobj
,	,	punct
by	IN	prep
hold	VBG	pcomp
that	IN	mark
even	RB	advmod
if	IN	mark
such	JJ	amod
investigation	NN	nsubj
should	MD	aux
succeed	VB	advcl
,	,	punct
a	DT	det
patent	NN	nsubj
be	VBZ	ccomp
not	RB	neg
available	JJ	acomp
.	.	punct

 	_SP	

From	IN	prep
-PRON-	PRP$	poss
colleague	NNS	poss
'	POS	case
invalidation	NN	pobj
of	IN	prep
the	DT	det
patent	NN	pobj
on	IN	prep
this	DT	det
significant	JJ	amod
medical	JJ	amod
advance	NN	pobj
,	,	punct
-PRON-	PRP	nsubj
respectfully	RB	advmod
dissent	NN	ROOT
.	.	punct

 	_SP	

all	DT	det
Citations	NNPS	nsubj

 	_SP	
748	CD	nummod
f.3d	CD	appos
1326	CD	nummod
,	,	punct
110	CD	nummod
U.S.P.Q.2d	NNP	appos
1494	CD	nummod

 	_SP	
Footnotes	NNP	ROOT

 	_SP	

Circuit	NNP	compound
Judge	NNP	compound
Bryson	NNP	nsubj
participate	VBD	ROOT
only	RB	advmod
in	IN	prep
the	DT	det
decision	NN	pobj
on	IN	prep
the	DT	det
petition	NN	pobj
for	IN	prep
rehearing	NN	pcomp
.	.	punct

 	_SP	

U.S.	NNP	compound
patent	NN	compound
No.	SYM	compound
6,143,326	CD	ROOT
(	-LRB-	punct
file	VBN	acl
April	NNP	npadvmod
1	CD	nummod
,	,	punct
1997	CD	nummod
)	-RRB-	punct
.	.	punct

 	_SP	

Update	NNP	ROOT
:	:	punct
Bisphosphonates	NNPS	appos
,	,	punct
LUNAR	NNP	compound
NEWS	NNP	conj
,	,	punct
Spring	NNP	npadvmod
,	,	punct
27	CD	nummod
-	SYM	punct
29	CD	prep
(	-LRB-	punct
1999	CD	appos
)	-RRB-	punct
.	.	punct

 	_SP	

U.S.	NNP	compound
patent	NN	compound
No.	SYM	ROOT
6,468,559	CD	nummod
(	-LRB-	punct
file	VBN	acl
April	NNP	npadvmod
28	CD	nummod
,	,	punct
2000	CD	nummod
)	-RRB-	punct
.	.	punct

 	_SP	

U.S.	NNP	compound
patent	NN	compound
No.	SYM	ROOT
5,616,560	CD	nummod
(	-LRB-	punct
file	VBN	acl
March	NNP	npadvmod
20	CD	nummod
,	,	punct
1996	CD	nummod
)	-RRB-	punct
.	.	punct

 	_SP	

U.S.	NNP	compound
Patent	NNP	compound
Application	NNP	compound
Pub	NNP	ROOT
.	.	punct

No.2003/0118634	NNP	ROOT
(	-LRB-	punct
file	VBN	relcl
December	NNP	npadvmod
17	CD	nummod
,	,	punct
2002	CD	nummod
)	-RRB-	punct
.	.	punct

 	_SP	

BJ	NNP	compound
Riis	NNP	compound
et	NNP	compound
al	NNP	subtok
.	.	dep
,	,	punct
Ibandronate	NNP	ROOT
:	:	punct

a	DT	det
Comparison	NNP	ROOT
of	IN	prep
Oral	NNP	compound
Daily	NNP	compound
dose	VBG	compound
Versus	NNP	compound
Intermittent	NNP	compound
dose	VBG	pobj
in	IN	prep
Postmenopausal	NNP	compound
Osteoporosis	NNP	pobj
,	,	punct
16	CD	nummod
J.	NNP	compound
BONE	NNP	compound
MIN	NNP	appos
.	.	punct

RES	NNP	ROOT
.	.	punct
,	,	punct

10	CD	ROOT
,	,	punct
1871	CD	npadvmod
-	SYM	punct
78	CD	prep
(	-LRB-	punct
1997	CD	npadvmod
)	-RRB-	punct
.	.	punct

 	_SP	

R.	NNP	compound
Recker	NNP	compound
et	NNP	compound
al	NNP	subtok
.	.	ROOT
,	,	punct

insufficiently	RB	advmod
Dosed	NNP	compound
Intravenous	NNP	compound
Ibandronate	NNP	compound
Injections	NNPS	nsubjpass
be	VBP	auxpass
associate	VBN	ROOT
with	IN	prep
Suboptimal	NNP	compound
Antifracture	NNP	compound
Efficacy	NNP	pobj
in	IN	prep
Postmenopausal	NNP	compound
Osteoporosis	NNP	pobj
,	,	punct
34	CD	nummod
bone	NN	npadvmod
890	CD	nummod
(	-LRB-	punct
2004	CD	appos
)	-RRB-	punct
.	.	punct

 	_SP	

P.	NNP	compound
Ravn	NNP	compound
et	NNP	compound
al	NNP	subtok
.	.	ROOT
,	,	punct
the	DT	det
Effect	NNP	appos
of	IN	prep
Bone	NNP	compound
Mass	NNP	pobj
and	CC	cc
Bone	NNP	compound
Markers	NNPS	conj
of	IN	prep
Different	NNP	compound
Doses	NNPS	pobj
of	IN	prep
Ibandronate	NNP	pobj
:	:	punct

a	DT	det
New	NNP	compound
Bisphosphonate	NNP	ROOT
for	IN	prep
Prevention	NNP	pobj
and	CC	cc
Treatment	NNP	conj
of	IN	prep
Postmenopausal	NNP	compound
Osteoporosis	NNP	pobj
:	:	punct

a	DT	det
1-year	CD	ROOT
randomize	VBN	acl
,	,	punct
double	JJ	amod
-	HYPH	punct
Blind	NNP	conj
,	,	punct
Placebo	NNP	compound
-	HYPH	punct
control	VBN	amod
Dose	NNP	compound
-	HYPH	punct
Finding	NNP	compound
Study	NNP	conj
,	,	punct
15	CD	nummod
BONE	NNP	appos
527	CD	npadvmod
-	SYM	punct
33	CD	prep
(	-LRB-	punct
1996	CD	npadvmod
)	-RRB-	punct
.	.	punct

 	_SP	

U.S.	NNP	compound
patent	NN	compound
No.	SYM	compound
6,432,932	CD	ROOT
(	-LRB-	punct
file	VBN	acl
September	NNP	npadvmod
2	CD	nummod
,	,	punct
1999	CD	nummod
)	-RRB-	punct
.	.	punct

 	_SP	

Jean	NNP	compound
-	HYPH	punct
Yves	NNP	compound
Reginster	NNP	compound
et	NNP	compound
al	NNP	subtok
.	.	dep
,	,	punct
Monthly	NNP	compound
Oral	NNP	compound
Ibandronate	NNP	nsubj
be	VBZ	ROOT
well	RB	intj
-	HYPH	punct
tolerate	VBN	acomp
and	CC	cc
Efficacious	NNP	conj
in	IN	prep
Postmenopausal	NNP	compound
Women	NNPS	pobj
:	:	punct

result	NNS	ROOT
From	IN	prep
the	DT	det
Monthly	NNP	compound
Oral	NNP	compound
Pilot	NNP	compound
Study	NNP	pobj
,	,	punct
90	CD	nummod
j.	NN	appos
of	IN	prep
CLIN	NNP	pobj
.	.	punct

ENDOCRIN	NNP	subtok
.	.	ROOT
&	CC	cc
METAB	NNP	conj
..	NFP	punct

5018	CD	ROOT
-	SYM	punct
24	CD	prep
(	-LRB-	punct
2005	CD	appos
)	-RRB-	punct
.	.	punct

 	_SP	

Carey	NNP	compound
Krause	NNP	ROOT
,	,	punct
Roche	NNP	nmod
,	,	punct
glaxosmithkline	NN	appos
in	IN	prep
Drug	NNP	compound
Pact	NNP	pobj
,	,	punct
Chem	NNP	npadvmod
.	.	punct

market	NN	compound
reporter	NN	ROOT
,	,	punct
December	NNP	npadvmod
17	CD	nummod
,	,	punct
2001	CD	nummod
.	.	punct

 	_SP	

